lorglumide: RN given refers to (+-)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
lorglumide : A racemate comprising equal amounts of (R)- and (S)-lorglumide. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
N(2)-(3,4-dichlorobenzoyl)-N,N-dipentyl-alpha-glutamine : A dicarboxylic acid monoamide obtained by formal condensation of the alpha-carboxy group of N-(3,4-dichlorobenzoyl)glutamic acid with the amino group of dipentylamine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 3960 |
| CHEMBL ID | 24938 |
| CHEBI ID | 88307 |
| SCHEMBL ID | 149509 |
| MeSH ID | M0138779 |
| Synonym |
|---|
| BRD-A29854054-236-03-5 |
| gtpl891 |
| cr-1409 |
| SPECTRUM_001628 |
| PRESTWICK3_000915 |
| BPBIO1_000870 |
| pentanoic acid, 4-((3,4-dichlorobenzoyl)amino)-5-(dipentylamino)-5-oxo-, (+-)- |
| ccris 6857 |
| lorglumidum [latin] |
| lorglumida [spanish] |
| 4-((3,4-dichlorobenzoyl)amino)-5-(dipentylamino)-5-oxopentanoic acid |
| d,l-4-(3,4-dichlorobenzoylamino)-5-(dipentylamino)-5-oxo-pentanoic acid |
| (+-)-4-(3,4-dichlorobenzamido)-n,n-dipentylglutaramic acid |
| lorglumide [inn] |
| PDSP2_000867 |
| BSPBIO_000790 |
| PRESTWICK2_000915 |
| LOPAC0_000731 |
| PDSP1_000881 |
| lorglumide |
| KBIO2_004676 |
| KBIO2_002108 |
| KBIO2_007244 |
| KBIOSS_002108 |
| PRESTWICK1_000915 |
| PRESTWICK0_000915 |
| SPBIO_002979 |
| HMS2090O20 |
| CHEMBL24938 , |
| chebi:88307 , |
| L000350 |
| 97964-56-2 |
| bdbm50008170 |
| 4-(3,4-dichloro-benzoylamino)-4-dipentylcarbamoyl-butyric acid |
| 4-[(3,4-dichlorobenzoyl)amino]-5-(dipentylamino)-5-oxopentanoic acid |
| lad1uq73be , |
| unii-lad1uq73be |
| lorglumida |
| lorglumidum |
| (+/-)-4-(3,4-dichlorobenzamido)-n,n-dipentylglutaramic acid |
| pentanoic acid, 4-((3,4-dichlorobenzoyl)amino)-5-(dipentylamino)-5-oxo- |
| dl-4-(3,4-dichlorobenzoylamino)-5-(dipentylamino)-5-oxopentanoic acid |
| SCHEMBL149509 |
| AB01275506-01 |
| DTXSID2046961 |
| n(2)-(3,4-dichlorobenzoyl)-n,n-dipentyl-alpha-glutamine |
| SBI-0050709.P002 |
| 4-(3,4-dichlorobenzamido)-5-(dipentylamino)-5-oxopentanoic acid |
| Q12745785 |
| BRD-A29854054-236-07-6 |
| SDCCGSBI-0050709.P003 |
| pentanoic acid,4-[(3,4-dichlorobenzoyl)amino]-5-(dipentylamino)-5-oxo- |
| Excerpt | Reference |
|---|---|
| "Lorglumide was able to inhibit the functional responses elicited by exogenous CCK administration in both pancreas, stomach and gallbladder, while deramciclane was not effective under such circumstances." | ( Burghardt, B; Gacsályi, I; Kordás, K; Szénási, G; Varga, G, 1999) |
| Excerpt | Reference |
|---|---|
| "Pretreatment with lorglumide blocked the reducing effect of P." | ( Bombardelli, E; Cabras, C; Carai, MA; Colombo, G; Donzelli, F; Fantini, N; Gessa, GL; Lobina, C; Morazzoni, P; Riva, A, 2009) |
| "Pretreatment with lorglumide (1.0 mg/kg ip), a selective CCK-A receptor antagonist, reversed CCK-induced inhibition of sucrose intake." | ( Covasa, M; Hayes, MR; Savastano, DM, 2004) |
| "Pretreatment with lorglumide, a CCK(1) receptor blocker, reversed the stimulation of amylase release produced by intraduodenal application of ghrelin." | ( Jaworek, J; Konturek, SJ; Kot, M; Leja-Szpak, A; Macko, M; Mitis-Musioł, M; Nawrot-Porabka, K; Pawlik, WW; Szklarczyk, J, 2007) |
| "pretreatment with lorglumide (0.1-10 pg) but not PD135,158 (1-100 pg) dose dependently reversed CCK's inhibition of the tail-flick response induced by CWSS." | ( Kim, KW; Kim, YH; Kwon, SH; Min, BH; Song, DK; Suh, HW, 1996) |
| "Pretreatment with lorglumide caused a dose-dependent rightward shift of the dose-response curve, indicating competitive antagonism." | ( Almegård, B; Andersson, SE; Bill, A, 1990) |
| Class | Description |
|---|---|
| glutamic acid derivative | An amino acid derivative resulting from reaction of glutamic acid at the amino group or either of the carboxy groups, or from the replacement of any hydrogen by a heteroatom. The definition normally excludes peptides containing glutamic acid residues. |
| dicarboxylic acid monoamide | |
| benzamides | |
| dichlorobenzene | Any member of the class of chlorobenzenes carrying two chloro groups at unspecified positions. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
lorglumide is involved in 3 pathway(s), involving a total of 75 unique proteins and 90 unique compounds
| Pathway | Proteins | Compounds |
|---|---|---|
| D-Glutamine and D-Glutamate Metabolism | 15 | 17 |
| Peptidoglycan Biosynthesis I | 30 | 36 |
| Peptidoglycan Biosynthesis II | 30 | 37 |
| Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | IC50 (µMol) | 0.0340 | 0.0000 | 0.4362 | 4.3000 | AID52912; AID53038 |
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | Ki | 0.1290 | 0.0001 | 0.2789 | 2.8900 | AID50500 |
| Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | IC50 (µMol) | 2.2000 | 0.0004 | 1.1380 | 3.5000 | AID52568 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID51292 | Ratio of IC50 against CCK-B1 and CCK-B(B2) binding | 1992 | Journal of medicinal chemistry, Jan, Volume: 35, Issue:1 | Structure-antigastrin activity relationships of new (R)-4-benzamido-5-oxopentanoic acid derivatives. |
| AID52568 | Inhibition of binding of [125I]- CCK-33 to guinea pig cortex | 1990 | Journal of medicinal chemistry, Feb, Volume: 33, Issue:2 | Novel glutamic acid derived cholecystokinin receptor ligands. |
| AID53038 | Inhibition of binding of [125I]- CCK-33 to rat pancreas | 1990 | Journal of medicinal chemistry, Feb, Volume: 33, Issue:2 | Novel glutamic acid derived cholecystokinin receptor ligands. |
| AID52912 | Concentration required to inhibit by 50% specific binding of [125I](BH)-CCK-8 to cholecystokinin type A receptor in rat pancreatic acini | 1992 | Journal of medicinal chemistry, Jan, Volume: 35, Issue:1 | Structure-antigastrin activity relationships of new (R)-4-benzamido-5-oxopentanoic acid derivatives. |
| AID51288 | Concentration required to inhibit by 50% the specific binding of [3H]pentagastrin to cholecystokinin type B receptor in rabbit gastric gland | 1992 | Journal of medicinal chemistry, Jan, Volume: 35, Issue:1 | Structure-antigastrin activity relationships of new (R)-4-benzamido-5-oxopentanoic acid derivatives. |
| AID717844 | Inhibition of mouse Ido2 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation at 20 uM after 45 mins by spectrophotometric analysis relative to control | 2012 | Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24 | Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2. |
| AID50511 | Ratio between IC50 CCK-A vs IC50 CCK-B(B2) | 1992 | Journal of medicinal chemistry, Jan, Volume: 35, Issue:1 | Structure-antigastrin activity relationships of new (R)-4-benzamido-5-oxopentanoic acid derivatives. |
| AID50966 | Inhibition of binding of [125I]gastrin to Cholecystokinin type B receptor from guinea pig gastric glands | 1990 | Journal of medicinal chemistry, Feb, Volume: 33, Issue:2 | Novel glutamic acid derived cholecystokinin receptor ligands. |
| AID51443 | Inhibition of the specific binding of [125I](BH)-CCK-8 to Cholecystokinin type B receptor in rat brain cortex | 1992 | Journal of medicinal chemistry, Jan, Volume: 35, Issue:1 | Structure-antigastrin activity relationships of new (R)-4-benzamido-5-oxopentanoic acid derivatives. |
| AID50500 | Binding affinity against Cholecystokinin type A receptor using [125I](BH)-CCK-8 as radioligand in rat pancreas. | 1996 | Journal of medicinal chemistry, Feb-16, Volume: 39, Issue:4 | Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors. |
| AID493017 | Wombat Data for BeliefDocking | 1991 | Journal of medicinal chemistry, Dec, Volume: 34, Issue:12 | Cholecystokinin antagonists: (R)-tryptophan-based hybrid antagonists of high affinity and selectivity for CCK-A receptors. |
| AID1346809 | Rat CCK1 receptor (Cholecystokinin receptors) | 1990 | Proceedings of the National Academy of Sciences of the United States of America, Sep, Volume: 87, Issue:17 | Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. |
| AID1346809 | Rat CCK1 receptor (Cholecystokinin receptors) | 1987 | Pancreas, , Volume: 2, Issue:1 | CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini. |
| AID1346883 | Human CCK2 receptor (Cholecystokinin receptors) | 1996 | Neuropeptides, Aug, Volume: 30, Issue:4 | Pharmacological characterization of a Chinese hamster ovary cell line transfected with the human CCK-B receptor gene. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 42 (21.99) | 18.7374 |
| 1990's | 88 (46.07) | 18.2507 |
| 2000's | 43 (22.51) | 29.6817 |
| 2010's | 18 (9.42) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (1.01%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 197 (98.99%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|---|---|---|---|---|---|
| sincalide | [no description available] | medium | 68 | 0 | oligopeptide | |
| pentagastrin | [no description available] | medium | 8 | 0 | organic molecular entity | |
| benzotript | [no description available] | medium | 8 | 0 | ||
| a 65186 | [no description available] | medium | 1 | 0 | ||
| ci 988 | [no description available] | medium | 6 | 0 | ||
| proglumide | [no description available] | medium | 193 | 0 | benzamides; dicarboxylic acid monoamide; glutamine derivative; racemate | anti-ulcer drug; cholecystokinin antagonist; cholinergic antagonist; delta-opioid receptor agonist; drug metabolite; gastrointestinal drug; opioid analgesic; xenobiotic metabolite |
| devazepide | [no description available] | medium | 32 | 0 | 1,4-benzodiazepinone; indolecarboxamide | antineoplastic agent; apoptosis inducer; cholecystokinin antagonist; gastrointestinal drug |
| l 365260 | [no description available] | medium | 7 | 0 | benzodiazepine | |
| u 69593 | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; N-alkylpyrrolidine; organic heterobicyclic compound; oxaspiro compound | anti-inflammatory agent; diuretic; kappa-opioid receptor agonist |
| tifluadom | [no description available] | medium | 1 | 0 | benzodiazepine | |
| u-50488 | [no description available] | medium | 2 | 0 | dichlorobenzene; monocarboxylic acid amide; N-alkylpyrrolidine | analgesic; antitussive; calcium channel blocker; diuretic; kappa-opioid receptor agonist |
| a 71378 | [no description available] | medium | 1 | 0 | ||
| quinacrine | [no description available] | medium | 1 | 0 | acridines; aromatic ether; organochlorine compound; tertiary amino compound | antimalarial; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor |
| aa 861 | [no description available] | medium | 1 | 0 | 1,4-benzoquinones; acetylenic compound; primary alcohol | EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; ferroptosis inhibitor |
| albendazole | [no description available] | medium | 1 | 0 | aryl sulfide; benzimidazoles; benzimidazolylcarbamate fungicide; carbamate ester | anthelminthic drug; microtubule-destabilising agent; tubulin modulator |
| alfuzosin | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; quinazolines; tetrahydrofuranol | alpha-adrenergic antagonist; antihypertensive agent; antineoplastic agent |
| bay h 4502 | [no description available] | medium | 1 | 0 | biphenyls; imidazoles | |
| carvedilol | [no description available] | medium | 1 | 0 | carbazoles; secondary alcohol; secondary amino compound | alpha-adrenergic antagonist; antihypertensive agent; beta-adrenergic antagonist; cardiovascular drug; vasodilator agent |
| clotrimazole | [no description available] | medium | 1 | 0 | conazole antifungal drug; imidazole antifungal drug; imidazoles; monochlorobenzenes | antiinfective agent; environmental contaminant; xenobiotic |
| dipyridamole | [no description available] | medium | 1 | 0 | piperidines; pyrimidopyrimidine; tertiary amino compound; tetrol | adenosine phosphodiesterase inhibitor; EC 3.5.4.4 (adenosine deaminase) inhibitor; platelet aggregation inhibitor; vasodilator agent |
| disulfiram | [no description available] | medium | 1 | 0 | organic disulfide; organosulfur acaricide | angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; EC 3.1.1.1 (carboxylesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; ferroptosis inducer; fungicide; NF-kappaB inhibitor |
| econazole | [no description available] | medium | 1 | 0 | dichlorobenzene; ether; imidazoles; monochlorobenzenes | |
| felodipine | [no description available] | medium | 1 | 0 | dichlorobenzene; dihydropyridine; ethyl ester; methyl ester | anti-arrhythmia drug; antihypertensive agent; calcium channel blocker; vasodilator agent |
| fenofibrate | [no description available] | medium | 1 | 0 | aromatic ether; chlorobenzophenone; isopropyl ester; monochlorobenzenes | antilipemic drug; environmental contaminant; geroprotector; xenobiotic |
| ketoconazole | [no description available] | medium | 1 | 0 | dichlorobenzene; dioxolane; ether; imidazoles; N-acylpiperazine; N-arylpiperazine | |
| lansoprazole | [no description available] | medium | 1 | 0 | benzimidazoles; pyridines; sulfoxide | anti-ulcer drug; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor |
| mebendazole | [no description available] | medium | 1 | 0 | aromatic ketone; benzimidazoles; carbamate ester | antinematodal drug; microtubule-destabilising agent; tubulin modulator |
| miconazole | [no description available] | medium | 1 | 0 | dichlorobenzene; ether; imidazoles | |
| nicardipine | [no description available] | medium | 2 | 0 | benzenes; C-nitro compound; diester; dihydropyridine; methyl ester; tertiary amino compound | |
| nifedipine | [no description available] | medium | 2 | 0 | C-nitro compound; dihydropyridine; methyl ester | calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent |
| nimodipine | [no description available] | medium | 1 | 0 | 2-methoxyethyl ester; C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; isopropyl ester | antihypertensive agent; calcium channel blocker; cardiovascular drug; vasodilator agent |
| nisoldipine | [no description available] | medium | 1 | 0 | C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; methyl ester | |
| nitrendipine | [no description available] | medium | 1 | 0 | C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; ethyl ester; methyl ester | antihypertensive agent; calcium channel blocker; geroprotector; vasodilator agent |
| pantoprazole | [no description available] | medium | 1 | 0 | aromatic ether; benzimidazoles; organofluorine compound; pyridines; sulfoxide | anti-ulcer drug; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; environmental contaminant; xenobiotic |
| sulconazole | [no description available] | medium | 1 | 0 | dichlorobenzene; imidazoles; monochlorobenzenes; organic sulfide | |
| tioconazole | [no description available] | medium | 1 | 0 | dichlorobenzene; ether; imidazoles; thiophenes | |
| tranexamic acid | [no description available] | medium | 1 | 0 | amino acid | |
| trequinsin | [no description available] | medium | 1 | 0 | pyridopyrimidine | |
| troglitazone | [no description available] | medium | 1 | 0 | chromanes; thiazolidinone | anticoagulant; anticonvulsant; antineoplastic agent; antioxidant; EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor; ferroptosis inhibitor; hypoglycemic agent; platelet aggregation inhibitor; vasodilator agent |
| fentiazac | [no description available] | medium | 1 | 0 | thiazoles | |
| bromocriptine | [no description available] | medium | 1 | 0 | indole alkaloid | antidyskinesia agent; antiparkinson drug; dopamine agonist; hormone antagonist |
| oxfendazole | [no description available] | medium | 1 | 0 | benzimidazoles; carbamate ester; sulfoxide | antinematodal drug |
| captopril | [no description available] | medium | 2 | 0 | alkanethiol; L-proline derivative; N-acylpyrrolidine; pyrrolidinemonocarboxylic acid | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor |
| zileuton | [no description available] | medium | 1 | 0 | 1-benzothiophenes; ureas | anti-asthmatic drug; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; ferroptosis inhibitor; leukotriene antagonist; non-steroidal anti-inflammatory drug |
| efavirenz | [no description available] | medium | 1 | 0 | acetylenic compound; benzoxazine; cyclopropanes; organochlorine compound; organofluorine compound | antiviral drug; HIV-1 reverse transcriptase inhibitor |
| sertaconazole | [no description available] | medium | 1 | 0 | 1-benzothiophenes; dichlorobenzene; ether; imidazoles | |
| telmisartan | [no description available] | medium | 1 | 0 | benzimidazoles; biphenyls; carboxybiphenyl | angiotensin receptor antagonist; antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; environmental contaminant; xenobiotic |
| albendazole sulfoxide | [no description available] | medium | 1 | 0 | sulfoxide | |
| tretinoin | [no description available] | medium | 1 | 0 | retinoic acid; vitamin A | anti-inflammatory agent; antineoplastic agent; antioxidant; AP-1 antagonist; human metabolite; keratolytic drug; retinoic acid receptor agonist; retinoid X receptor agonist; signalling molecule |
| tenatoprazole | [no description available] | medium | 1 | 0 | imidazopyridine | |
| cilnidipine | [no description available] | medium | 1 | 0 | 2-methoxyethyl ester; C-nitro compound; dihydropyridine | antihypertensive agent; calcium channel blocker; cardiovascular drug |
| levetiracetam | [no description available] | medium | 1 | 0 | pyrrolidin-2-ones | anticonvulsant; environmental contaminant; xenobiotic |
| fenretinide | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; retinoid | antineoplastic agent; antioxidant |
| iloprost | [no description available] | medium | 1 | 0 | carbobicyclic compound; monocarboxylic acid; secondary alcohol | platelet aggregation inhibitor; vasodilator agent |
| lacidipine | [no description available] | medium | 1 | 0 | cinnamate ester; tert-butyl ester | |
| oxiconazole | [no description available] | medium | 1 | 0 | conazole antifungal drug; dichlorobenzene; imidazole antifungal drug; imidazoles; oxime O-ether | antiinfective agent |
| sildenafil | [no description available] | medium | 1 | 0 | piperazines; pyrazolopyrimidine; sulfonamide | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent |
| cholecystokinin | [no description available] | medium | 121 | 0 | ||
| peptide yy | [no description available] | medium | 2 | 0 | ||
| 2-(2-(5-bromo-1h-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3h)-quinazolinone | [no description available] | medium | 4 | 0 | quinazolines | |
| oleic acid | [no description available] | medium | 6 | 0 | octadec-9-enoic acid | antioxidant; Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; Escherichia coli metabolite; mouse metabolite; plant metabolite; solvent |
| ginsenoside rb1 | [no description available] | medium | 1 | 0 | ginsenoside; glycoside; tetracyclic triterpenoid | anti-inflammatory drug; anti-obesity agent; apoptosis inhibitor; neuroprotective agent; plant metabolite; radical scavenger |
| ginsenosides | [no description available] | medium | 1 | 0 | ||
| guanosine 5'-o-(2-thiodiphosphate) | [no description available] | medium | 1 | 0 | nucleoside diphosphate analogue | |
| gamma-aminobutyric acid | [no description available] | medium | 1 | 0 | amino acid zwitterion; gamma-amino acid; monocarboxylic acid | human metabolite; neurotransmitter; Saccharomyces cerevisiae metabolite; signalling molecule |
| guanosine diphosphate | [no description available] | medium | 1 | 0 | guanosine 5'-phosphate; purine ribonucleoside 5'-diphosphate | Escherichia coli metabolite; mouse metabolite; uncoupling protein inhibitor |
| luzindole | [no description available] | medium | 2 | 0 | acetamides; indoles | melatonin receptor antagonist |
| methacholine chloride | [no description available] | medium | 1 | 0 | quaternary ammonium salt | |
| melatonin | [no description available] | medium | 4 | 0 | acetamides; tryptamines | anticonvulsant; central nervous system depressant; geroprotector; hormone; human metabolite; immunological adjuvant; mouse metabolite; radical scavenger |
| pentobarbital | [no description available] | medium | 2 | 0 | barbiturates | GABAA receptor agonist |
| tetrodotoxin | [no description available] | medium | 7 | 0 | azatetracycloalkane; oxatetracycloalkane; quinazoline alkaloid | animal metabolite; bacterial metabolite; marine metabolite; neurotoxin; voltage-gated sodium channel blocker |
| atropine | [no description available] | medium | 8 | 0 | ||
| meglumine | [no description available] | medium | 14 | 0 | hexosamine; secondary amino compound | |
| pd 135158 | [no description available] | medium | 11 | 0 | ||
| leptin | [no description available] | medium | 1 | 0 | ||
| ng-nitroarginine methyl ester | [no description available] | medium | 3 | 0 | alpha-amino acid ester; L-arginine derivative; methyl ester; N-nitro compound | EC 1.14.13.39 (nitric oxide synthase) inhibitor |
| bradykinin | [no description available] | medium | 1 | 0 | oligopeptide | human blood serum metabolite; vasodilator agent |
| indomethacin | [no description available] | medium | 3 | 0 | aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole | analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic metabolite; xenobiotic |
| icatibant | [no description available] | medium | 1 | 0 | ||
| mocetinostat | [no description available] | medium | 1 | 0 | aminopyrimidine; benzamides; pyridines; secondary amino compound; secondary carboxamide; substituted aniline | antineoplastic agent; apoptosis inducer; autophagy inducer; cardioprotective agent; EC 3.5.1.98 (histone deacetylase) inhibitor; hepatotoxic agent |
| lysine | [no description available] | medium | 1 | 0 | aspartate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; lysine; organic molecular entity; proteinogenic amino acid | algal metabolite; anticonvulsant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
| oxytocin | [no description available] | medium | 3 | 0 | heterodetic cyclic peptide; peptide hormone | oxytocic; vasodilator agent |
| atosiban | [no description available] | medium | 3 | 0 | oligopeptide | |
| vasotocin | [no description available] | medium | 3 | 0 | ||
| piperidines | [no description available] | medium | 2 | 0 | ||
| sr141716 | [no description available] | medium | 1 | 0 | amidopiperidine; carbohydrazide; dichlorobenzene; monochlorobenzenes; pyrazoles | anti-obesity agent; appetite depressant; CB1 receptor antagonist |
| phenacetin | [no description available] | medium | 1 | 0 | acetamides; aromatic ether | cyclooxygenase 3 inhibitor; non-narcotic analgesic; peripheral nervous system drug |
| phenylalanylarginine | [no description available] | medium | 1 | 0 | dipeptide | metabolite |
| estradiol 3-benzoate | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; benzoate ester | estrogen receptor agonist; xenoestrogen |
| chlorpromazine | [no description available] | medium | 1 | 0 | organochlorine compound; phenothiazines; tertiary amine | anticoronaviral agent; antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; phenothiazine antipsychotic drug |
| camostat | [no description available] | medium | 7 | 0 | benzoate ester; carboxylic ester; diester; guanidines; tertiary carboxamide | anti-inflammatory agent; anticoronaviral agent; antifibrinolytic drug; antihypertensive agent; antineoplastic agent; antiviral agent; serine protease inhibitor |
| gabexate | [no description available] | medium | 8 | 0 | benzoate ester | |
| 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone | [no description available] | medium | 3 | 0 | ||
| tetragastrin | [no description available] | medium | 8 | 0 | peptidyl amide; tetrapeptide | anxiogenic; human metabolite |
| cr 2945 | [no description available] | medium | 5 | 0 | ||
| quinazolines | [no description available] | medium | 1 | 0 | azaarene; mancude organic heterobicyclic parent; ortho-fused heteroarene; quinazolines | |
| ondansetron | [no description available] | medium | 1 | 0 | carbazoles | |
| pyrimidinones | [no description available] | medium | 1 | 0 | ||
| enkephalin, methionine | [no description available] | medium | 1 | 0 | ||
| enkephalin, ala(2)-mephe(4)-gly(5)- | [no description available] | medium | 2 | 0 | ||
| 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline | [no description available] | medium | 1 | 0 | naphthalenes; sulfonic acid derivative | |
| quinoxalines | [no description available] | medium | 1 | 0 | mancude organic heterobicyclic parent; naphthyridine; ortho-fused heteroarene | |
| pirinixic acid | [no description available] | medium | 1 | 0 | aryl sulfide; organochlorine compound; pyrimidines | |
| capsaicin | [no description available] | medium | 3 | 0 | capsaicinoid | non-narcotic analgesic; TRPV1 agonist; voltage-gated sodium channel blocker |
| oleoylimidazolide | [no description available] | medium | 1 | 0 | ||
| biotin | [no description available] | medium | 1 | 0 | biotins; vitamin B7 | coenzyme; cofactor; Escherichia coli metabolite; fundamental metabolite; human metabolite; mouse metabolite; nutraceutical; prosthetic group; Saccharomyces cerevisiae metabolite |
| bicuculline | [no description available] | medium | 1 | 0 | benzylisoquinoline alkaloid; isoquinoline alkaloid; isoquinolines | agrochemical; central nervous system stimulant; GABA-gated chloride channel antagonist; GABAA receptor antagonist; neurotoxin |
| glutamic acid | [no description available] | medium | 1 | 0 | glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical |
| gastrins | [no description available] | medium | 11 | 0 | ||
| methacycline | [no description available] | medium | 1 | 0 | 1,2-diglyceride | |
| boc-tyr(s03)-nle-gly-trp-nle-asp-2-phenylethyl ester | [no description available] | medium | 4 | 0 | ||
| jmv 179 | [no description available] | medium | 2 | 0 | ||
| caseins | [no description available] | medium | 3 | 0 | ||
| tryptophan | [no description available] | medium | 1 | 0 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; tryptophan zwitterion; tryptophan | antidepressant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
| gastrin 17 | [no description available] | medium | 2 | 0 | gastrin | antineoplastic agent |
| phentolamine | [no description available] | medium | 1 | 0 | imidazoles; phenols; substituted aniline; tertiary amino compound | alpha-adrenergic antagonist; vasodilator agent |
| guanethidine | [no description available] | medium | 1 | 0 | azocanes; guanidines | adrenergic antagonist; antihypertensive agent; sympatholytic agent |
| carbachol | [no description available] | medium | 3 | 0 | ammonium salt; carbamate ester | cardiotonic drug; miotic; muscarinic agonist; nicotinic acetylcholine receptor agonist; non-narcotic analgesic |
| fura-2 | [no description available] | medium | 2 | 0 | ||
| tetradecanoylphorbol acetate | [no description available] | medium | 1 | 0 | acetate ester; diester; phorbol ester; tertiary alpha-hydroxy ketone; tetradecanoate ester | antineoplastic agent; apoptosis inducer; carcinogenic agent; mitogen; plant metabolite; protein kinase C agonist; reactive oxygen species generator |
| inosine triphosphate | [no description available] | medium | 1 | 0 | inosine phosphate; purine ribonucleoside 5'-triphosphate | Escherichia coli metabolite; human metabolite; mouse metabolite |
| staurosporine | [no description available] | medium | 1 | 0 | ammonium ion derivative | |
| ucn 1028 c | [no description available] | medium | 1 | 0 | ||
| neuromedin c | [no description available] | medium | 1 | 0 | ||
| omeprazole | [no description available] | medium | 1 | 0 | aromatic ether; benzimidazoles; pyridines; sulfoxide | |
| 9,10-dimethyl-1,2-benzanthracene | [no description available] | medium | 1 | 0 | ortho-fused polycyclic arene; tetraphenes | carcinogenic agent |
| ceruletide | [no description available] | medium | 12 | 0 | oligopeptide | diagnostic agent; gastrointestinal drug |
| loxiglumide | [no description available] | medium | 10 | 0 | organic molecular entity | |
| asperlicin | [no description available] | medium | 4 | 0 | ||
| tetronothiodin | [no description available] | medium | 1 | 0 | ||
| thiophenes | [no description available] | medium | 1 | 0 | mancude organic heteromonocyclic parent; monocyclic heteroarene; thiophenes; volatile organic compound | non-polar solvent |
| azaserine | [no description available] | medium | 5 | 0 | carboxylic ester; diazo compound; L-serine derivative; non-proteinogenic L-alpha-amino acid | antifungal agent; antimetabolite; antimicrobial agent; antineoplastic agent; glutamine antagonist; immunosuppressive agent; metabolite |
| acid phosphatase | [no description available] | medium | 1 | 0 | ||
| enkephalin, leucine | [no description available] | medium | 2 | 0 | pentapeptide; peptide zwitterion | analgesic; delta-opioid receptor agonist; human metabolite; mu-opioid receptor agonist; neurotransmitter; rat metabolite |
| beta-endorphin | [no description available] | medium | 1 | 0 | ||
| morphine | [no description available] | medium | 11 | 0 | morphinane alkaloid; organic heteropentacyclic compound; tertiary amino compound | anaesthetic; drug allergen; environmental contaminant; geroprotector; mu-opioid receptor agonist; opioid analgesic; plant metabolite; vasodilator agent; xenobiotic |
| enkephalin, d-penicillamine (2,5)- | [no description available] | medium | 2 | 0 | heterodetic cyclic peptide | delta-opioid receptor agonist |
| adenosine | [no description available] | medium | 1 | 0 | adenosines; purines D-ribonucleoside | analgesic; anti-arrhythmia drug; fundamental metabolite; human metabolite; vasodilator agent |
| n(6)-cyclopentyladenosine | [no description available] | medium | 1 | 0 | ||
| leucine | [no description available] | medium | 1 | 0 | amino acid zwitterion; L-alpha-amino acid; leucine; proteinogenic amino acid; pyruvate family amino acid | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite |
| 3-o-methylglucose | [no description available] | medium | 1 | 0 | D-aldohexose derivative | |
| dizocilpine maleate | [no description available] | medium | 1 | 0 | maleate salt; tetracyclic antidepressant | anaesthetic; anticonvulsant; neuroprotective agent; nicotinic antagonist; NMDA receptor antagonist |
| 3,4-dihydroxyphenylacetic acid | [no description available] | medium | 1 | 0 | catechols; dihydroxyphenylacetic acid | human metabolite |
| deramciclane | [no description available] | medium | 1 | 0 | ||
| dynorphins | [no description available] | medium | 1 | 0 | ||
| enkephalin, ser(2), leu(5), thr(6)- | [no description available] | medium | 1 | 0 | oligopeptide | |
| neurotensin | [no description available] | medium | 2 | 0 | peptide hormone | human metabolite; mitogen; neurotransmitter; vulnerary |
| spiroglumide | [no description available] | medium | 1 | 0 | ||
| furosemide | [no description available] | medium | 1 | 0 | chlorobenzoic acid; furans; sulfonamide | environmental contaminant; loop diuretic; xenobiotic |
| magnesium sulfate | [no description available] | medium | 1 | 0 | magnesium salt; metal sulfate; organic magnesium salt | anaesthetic; analgesic; anti-arrhythmia drug; anticonvulsant; calcium channel blocker; cardiovascular drug; fertilizer; tocolytic agent |
| methylcellulose | [no description available] | medium | 1 | 0 | ||
| n-methylnaloxone | [no description available] | medium | 1 | 0 | ||
| naltrexone | [no description available] | medium | 1 | 0 | cyclopropanes; morphinane-like compound; organic heteropentacyclic compound | antidote to opioid poisoning; central nervous system depressant; environmental contaminant; mu-opioid receptor antagonist; xenobiotic |
| naloxone | [no description available] | medium | 2 | 0 | morphinane alkaloid; organic heteropentacyclic compound; tertiary alcohol | antidote to opioid poisoning; central nervous system depressant; mu-opioid receptor antagonist |
| dexloxiglumide | [no description available] | medium | 1 | 0 | glutamic acid derivative | |
| taurocholic acid | [no description available] | medium | 3 | 0 | amino sulfonic acid; bile acid taurine conjugate | human metabolite |
| phenylalanine | [no description available] | medium | 1 | 0 | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; phenylalanine; proteinogenic amino acid | algal metabolite; EC 3.1.3.1 (alkaline phosphatase) inhibitor; Escherichia coli metabolite; human xenobiotic metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
| acebutolol | [no description available] | medium | 1 | 0 | alpha-D-glucosyl-(1->4)-D-mannopyranose | |
| potassium chloride | [no description available] | medium | 1 | 0 | inorganic chloride; inorganic potassium salt; potassium salt | fertilizer |
| hydrogen carbonate | [no description available] | medium | 7 | 0 | carbon oxoanion | cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
| 1-anilino-8-naphthalenesulfonate | [no description available] | medium | 1 | 0 | aminonaphthalene; naphthalenesulfonic acid | fluorescent probe |
| trypsinogen | [no description available] | medium | 1 | 0 | ||
| glucagon | [no description available] | medium | 3 | 0 | peptide hormone | |
| corticosterone | [no description available] | medium | 2 | 0 | 11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone | human metabolite; mouse metabolite |
| nitrosobis(2-oxopropyl)amine | [no description available] | medium | 3 | 0 | ketone; nitrosamine | carcinogenic agent |
| pirenzepine | [no description available] | medium | 1 | 0 | pyridobenzodiazepine | anti-ulcer drug; antispasmodic drug; muscarinic antagonist |
| hexamethonium | [no description available] | medium | 1 | 0 | quaternary ammonium salt | |
| bumetanide | [no description available] | medium | 1 | 0 | amino acid; benzoic acids; sulfonamide | diuretic; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor |
| quinpirole | [no description available] | medium | 1 | 0 | pyrazoloquinoline | dopamine agonist |
| ergoline | [no description available] | medium | 1 | 0 | diamine; ergoline alkaloid; indole alkaloid fundamental parent; indole alkaloid; organic heterotetracyclic compound | |
| glutamine | [no description available] | medium | 33 | 0 | amino acid zwitterion; glutamine family amino acid; glutamine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid | EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite |
| cr 1392 | [no description available] | medium | 2 | 0 | ||
| osteum | [no description available] | medium | 1 | 0 | organic molecular entity | |
| peptones | [no description available] | medium | 1 | 0 | ||
| dibutyryl cyclic gmp | [no description available] | medium | 1 | 0 | ||
| thymidine | [no description available] | medium | 1 | 0 | pyrimidine 2'-deoxyribonucleoside | Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite |
| n-methylscopolamine | [no description available] | medium | 1 | 0 | ||
| spermine | [no description available] | medium | 1 | 0 | polyazaalkane; tetramine | antioxidant; fundamental metabolite; immunosuppressive agent |
| spermidine | [no description available] | medium | 1 | 0 | polyazaalkane; triamine | autophagy inducer; fundamental metabolite; geroprotector |
| putrescine | [no description available] | medium | 1 | 0 | alkane-alpha,omega-diamine | antioxidant; fundamental metabolite |
| ethionine | [no description available] | medium | 1 | 0 | S-ethylhomocysteine | antimetabolite; carcinogenic agent |
| gastrin-releasing peptide | [no description available] | medium | 2 | 0 | ||
| benzofurans | [no description available] | medium | 1 | 0 | ||
| 3-methoxytyramine | [no description available] | medium | 1 | 0 | monomethoxybenzene; phenols; phenylethylamine; primary amino compound | biomarker; human blood serum metabolite; human urinary metabolite |
| cyclic gmp | [no description available] | medium | 1 | 0 | 3',5'-cyclic purine nucleotide; guanyl ribonucleotide | Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite |
| harmaline | [no description available] | medium | 1 | 0 | harmala alkaloid | oneirogen |
| dinoprostone | [no description available] | medium | 1 | 0 | prostaglandins E | human metabolite; mouse metabolite; oxytocic |
| haloperidol | [no description available] | medium | 1 | 0 | aromatic ketone; hydroxypiperidine; monochlorobenzenes; organofluorine compound; tertiary alcohol | antidyskinesia agent; antiemetic; dopaminergic antagonist; first generation antipsychotic; serotonergic antagonist |
| cisapride | [no description available] | medium | 1 | 0 | benzamides | |
| papaverine | [no description available] | medium | 1 | 0 | benzylisoquinoline alkaloid; dimethoxybenzene; isoquinolines | antispasmodic drug; vasodilator agent |
| pentylenetetrazole | [no description available] | medium | 1 | 0 | organic heterobicyclic compound; organonitrogen heterocyclic compound | |
| diazepam | [no description available] | medium | 1 | 0 | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; environmental contaminant; sedative; xenobiotic |
| 4-methylglutamic acid | [no description available] | low | 0 | 0 | amino dicarboxylic acid; glutamic acid derivative | |
| 2-Phthalimidoglutaricacid | [no description available] | low | 0 | 0 | glutamic acid derivative | |
| glutamic acid dimethyl ester | [no description available] | low | 0 | 0 | glutamic acid derivative | |
| isoglutamine | [no description available] | low | 0 | 0 | amino acid amide; glutamic acid derivative | |
| arginine glutamate | [no description available] | low | 0 | 0 | glutamic acid derivative | |
| gamma-glutamyl hydroxamate | [no description available] | low | 0 | 0 | amino acid zwitterion; glutamic acid derivative; hydroxamic acid | |
| 2-[(4-phenylphenyl)sulfonylamino]pentanedioic acid | [no description available] | low | 0 | 0 | glutamic acid derivative | |
| 2-[[[5-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methyl-3-furanyl]-oxomethyl]amino]pentanedioic acid dimethyl ester | [no description available] | low | 0 | 0 | glutamic acid derivative | |
| n-carbamylglutamate | [no description available] | low | 0 | 0 | glutamic acid derivative; ureas | human metabolite |
| edatrexate | [no description available] | low | 0 | 0 | glutamic acid derivative | |
| ag 2034 | [no description available] | low | 0 | 0 | glutamic acid derivative | |
| oxamic acid | [no description available] | low | 0 | 0 | dicarboxylic acid monoamide | Escherichia coli metabolite |
| phthalylsulfathiazole | [no description available] | low | 0 | 0 | 1,3-thiazoles; dicarboxylic acid monoamide; sulfonamide antibiotic; sulfonamide | |
| alpha-naphthylphthalamic acid | [no description available] | low | 0 | 0 | carboxylic acid; dicarboxylic acid monoamide; N-(1-naphthyl)carboxamide | herbicide |
| ioxitalamic acid | [no description available] | low | 0 | 0 | acetamides; benzoic acids; dicarboxylic acid monoamide; organoiodine compound | environmental contaminant; radioopaque medium; xenobiotic |
| coprine | [no description available] | low | 0 | 0 | cyclopropanes; dicarboxylic acid monoamide; L-glutamine derivative; non-proteinogenic L-alpha-amino acid | EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; metabolite; mycotoxin |
| tamibarotene | [no description available] | low | 0 | 0 | dicarboxylic acid monoamide; retinoid; tetralins | antineoplastic agent; retinoic acid receptor alpha/beta agonist |
| mannopine | [no description available] | low | 0 | 0 | amino acid opine; dicarboxylic acid monoamide; hexitol derivative; L-glutamine derivative; non-proteinogenic L-alpha-amino acid; secondary amino compound | plant metabolite |
| e 64 | [no description available] | low | 0 | 0 | dicarboxylic acid monoamide; epoxy monocarboxylic acid; guanidines; L-leucine derivative; zwitterion | antimalarial; antiparasitic agent; protease inhibitor |
| varespladib | [no description available] | low | 0 | 0 | aromatic ether; benzenes; dicarboxylic acid monoamide; indoles; monocarboxylic acid; primary carboxamide | anti-inflammatory drug; antidote; EC 3.1.1.4 (phospholipase A2) inhibitor |
| melagatran | [no description available] | low | 0 | 0 | azetidines; carboxamidine; dicarboxylic acid monoamide; non-proteinogenic alpha-amino acid; secondary amino compound | anticoagulant; EC 3.4.21.5 (thrombin) inhibitor; serine protease inhibitor |
| N-malonylanthranilic acid | [no description available] | low | 0 | 0 | dicarboxylic acid monoamide | |
| 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine | [no description available] | low | 0 | 0 | adenosines; dicarboxylic acid monoamide; monocarboxylic acid | adenosine A2A receptor agonist; anti-inflammatory agent |
| maleamic acid | [no description available] | low | 0 | 0 | alpha,beta-unsaturated monocarboxylic acid; dicarboxylic acid monoamide | bacterial xenobiotic metabolite; Escherichia coli metabolite |
| cathestatin b | [no description available] | low | 0 | 0 | dicarboxylic acid monoamide; epoxide; monocarboxylic acid; phenols; primary amino compound | antimicrobial agent; cysteine protease inhibitor; Penicillium metabolite |
| EG00229 | [no description available] | low | 0 | 0 | benzothiadiazole; dicarboxylic acid monoamide; L-arginine derivative; secondary carboxamide; sulfonamide; thiophenes | angiogenesis inhibitor; antineoplastic agent; neuropilin receptor antagonist |
| fumimycin | [no description available] | low | 0 | 0 | 1-benzofurans; dicarboxylic acid monoamide; gamma-lactone; monocarboxylic acid; polyphenol | antibacterial agent; Aspergillus metabolite; EC 3.5.1.88 (peptide deformylase) inhibitor |
| 3-aminobenzamide | [no description available] | low | 0 | 0 | benzamides; substituted aniline | EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor |
| dan 2163 | [no description available] | low | 0 | 0 | aromatic amide; aromatic amine; benzamides; pyrrolidines; sulfone | environmental contaminant; second generation antipsychotic; xenobiotic |
| benzamide | [no description available] | low | 0 | 0 | benzamides | |
| bromopride | [no description available] | low | 0 | 0 | benzamides | |
| ci 994 | [no description available] | low | 0 | 0 | acetamides; benzamides; substituted aniline | antineoplastic agent; EC 3.5.1.98 (histone deacetylase) inhibitor |
| 2-hexyloxybenzamide | [no description available] | low | 0 | 0 | aromatic ether; benzamides | antifungal agent |
| itopride | [no description available] | low | 0 | 0 | benzamides | |
| labetalol | [no description available] | low | 0 | 0 | benzamides; benzenes; phenols; primary carboxamide; salicylamides; secondary alcohol; secondary amino compound | |
| 4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide | [no description available] | low | 0 | 0 | benzamides; hydroxamic acid; secondary carboxamide; tertiary amino compound | antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor |
| metoclopramide | [no description available] | low | 0 | 0 | benzamides; monochlorobenzenes; substituted aniline; tertiary amino compound | antiemetic; dopaminergic antagonist; environmental contaminant; gastrointestinal drug; xenobiotic |
| moclobemide | [no description available] | low | 0 | 0 | benzamides; monochlorobenzenes; morpholines | antidepressant; environmental contaminant; xenobiotic |
| entinostat | [no description available] | low | 0 | 0 | benzamides; carbamate ester; primary amino compound; pyridines; substituted aniline | antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor |
| deet | [no description available] | low | 0 | 0 | benzamides; monocarboxylic acid amide | environmental contaminant; insect repellent; xenobiotic |
| acecainide | [no description available] | low | 0 | 0 | acetamides; benzamides | anti-arrhythmia drug |
| nemonapride | [no description available] | low | 0 | 0 | benzamides; monochlorobenzenes; monomethoxybenzene; N-alkylpyrrolidine; secondary amino compound; secondary carboxamide; substituted aniline | |
| niclosamide | [no description available] | low | 0 | 0 | benzamides; C-nitro compound; monochlorobenzenes; salicylanilides; secondary carboxamide | anthelminthic drug; anticoronaviral agent; antiparasitic agent; apoptosis inducer; molluscicide; piscicide; STAT3 inhibitor |
| picotamide | [no description available] | low | 0 | 0 | benzamides | |
| procainamide | [no description available] | low | 0 | 0 | benzamides | anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker |
| procarbazine | [no description available] | low | 0 | 0 | benzamides; hydrazines | antineoplastic agent |
| proglumetacin | [no description available] | low | 0 | 0 | aromatic ether; benzamides; carboxylic ester; monochlorobenzenes; N-acylindole; N-alkylpiperazine | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; lipoxygenase inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug |
| imatinib | [no description available] | low | 0 | 0 | aromatic amine; benzamides; N-methylpiperazine; pyridines; pyrimidines | antineoplastic agent; apoptosis inducer; tyrosine kinase inhibitor |
| sulpiride | [no description available] | low | 0 | 0 | benzamides; N-alkylpyrrolidine; sulfonamide | antidepressant; antiemetic; antipsychotic agent; dopaminergic antagonist |
| tiapride | [no description available] | low | 0 | 0 | benzamides | |
| trimethobenzamide | [no description available] | low | 0 | 0 | benzamides; tertiary amino compound | antiemetic |
| troxipide | [no description available] | low | 0 | 0 | benzamides | |
| zm 336372 | [no description available] | low | 0 | 0 | benzamides | |
| iodohippuric acid | [no description available] | low | 0 | 0 | benzamides; N-acylglycine; organoiodine compound | |
| benzoylarginine-2-naphthylamide | [no description available] | low | 0 | 0 | arginine derivative; benzamides; N-(2-naphthyl)carboxamide | |
| 4-(benzoylamino)-2-hydroxybenzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| ameltolide | [no description available] | low | 0 | 0 | benzamides | |
| antimycin a | [no description available] | low | 0 | 0 | benzamides; formamides; macrodiolide; phenols | antifungal agent; mitochondrial respiratory-chain inhibitor; piscicide |
| rebemide | [no description available] | low | 0 | 0 | benzamides | |
| 2,6-dichlorobenzamide | [no description available] | low | 0 | 0 | benzamides; dichlorobenzene | herbicide; marine xenobiotic metabolite |
| fluorophene | [no description available] | low | 0 | 0 | benzamides | |
| 2-toluanilide | [no description available] | low | 0 | 0 | benzamides; benzanilide fungicide | |
| 2-bromo-N-phenylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| xipamide | [no description available] | low | 0 | 0 | benzamides | |
| capobenic acid | [no description available] | low | 0 | 0 | benzamides | |
| pronamide | [no description available] | low | 0 | 0 | benzamides; dichlorobenzene; terminal acetylenic compound | agrochemical; herbicide |
| clanobutin | [no description available] | low | 0 | 0 | benzamides | |
| nitazoxanide | [no description available] | low | 0 | 0 | benzamides; carboxylic ester | |
| Flamprop | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-(dimethylamino)phenyl]-3,4,5-trimethoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| endralazine | [no description available] | low | 0 | 0 | benzamides | |
| flutolanil | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; aromatic ether; benzamides; benzanilide fungicide | antifungal agrochemical; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor |
| encainide | [no description available] | low | 0 | 0 | benzamides; piperidines | anti-arrhythmia drug; sodium channel blocker |
| nelfinavir | [no description available] | low | 0 | 0 | aryl sulfide; benzamides; organic heterobicyclic compound; phenols; secondary alcohol; tertiary amino compound | antineoplastic agent; HIV protease inhibitor |
| n-benzoylpiperidine | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| pancopride | [no description available] | low | 0 | 0 | benzamides | |
| octylonium | [no description available] | low | 0 | 0 | benzamides | |
| parsalmide | [no description available] | low | 0 | 0 | benzamides | |
| isoxaben | [no description available] | low | 0 | 0 | benzamides; isoxazoles | cellulose synthesis inhibitor; herbicide |
| 4-aminobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-Methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| benzoyltyrosine ethyl ester | [no description available] | low | 0 | 0 | benzamides; ethyl ester; L-tyrosine derivative; phenols | chromogenic compound |
| salifungin | [no description available] | low | 0 | 0 | benzamides | |
| n-benzoyl-l-arginine | [no description available] | low | 0 | 0 | benzamides; N-acyl-L-arginine | |
| gr 127935 | [no description available] | low | 0 | 0 | 1,2,4-oxadiazole; benzamides; N-alkylpiperazine; N-arylpiperazine | |
| zacopride | [no description available] | low | 0 | 0 | benzamides | |
| mozavaptan | [no description available] | low | 0 | 0 | benzamides | aquaretic |
| mosapride | [no description available] | low | 0 | 0 | aromatic ether; benzamides; monochlorobenzenes; monofluorobenzenes; morpholines; secondary carboxamide; substituted aniline; tertiary amino compound | |
| zoxamide | [no description available] | low | 0 | 0 | alpha-chloroketone; benzamides; dichlorobenzene | |
| procainamide 4-hydroxylamine | [no description available] | low | 0 | 0 | benzamides; hydroxylamines | drug metabolite |
| ly 188544 | [no description available] | low | 0 | 0 | benzamides | |
| gr 55562 | [no description available] | low | 0 | 0 | benzamides | |
| n-(2,6-dimethylphenyl)-4-(((diethylamino)acetyl)amino)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| tariquidar | [no description available] | low | 0 | 0 | benzamides | |
| n-benzoyltyrosine | [no description available] | low | 0 | 0 | benzamides; N-acyl-L-tyrosine | |
| rp 73401 | [no description available] | low | 0 | 0 | aromatic ether; benzamides; chloropyridine; monocarboxylic acid amide | anti-asthmatic drug; anti-inflammatory agent; bronchodilator agent; phosphodiesterase IV inhibitor |
| brovanexine | [no description available] | low | 0 | 0 | benzamides | |
| aminopotentidine | [no description available] | low | 0 | 0 | aromatic ether; benzamides; guanidines; nitrile; piperidines; substituted aniline | H2-receptor antagonist |
| asperphenamate | [no description available] | low | 0 | 0 | benzamides; carboxylic ester; L-phenylalanine derivative | antineoplastic agent |
| N-(3-fluorophenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| benzoylphenylalanine | [no description available] | low | 0 | 0 | benzamides; N-acyl-amino acid | |
| 2-methoxy-N-[2-(methylthio)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-(4-fluorobenzoylamino)benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzamides | |
| xv 638 | [no description available] | low | 0 | 0 | 1,3-thiazoles; benzamides; diazepanone; diol; secondary alcohol; secondary carboxamide; ureas | HIV protease inhibitor |
| roflumilast | [no description available] | low | 0 | 0 | aromatic ether; benzamides; chloropyridine; cyclopropanes; organofluorine compound | anti-asthmatic drug; phosphodiesterase IV inhibitor |
| 2-(3-benzamidophenoxy)acetic acid | [no description available] | low | 0 | 0 | benzamides | |
| ck-0944666 | [no description available] | low | 0 | 0 | benzamides; indoles; organofluorine compound | actin polymerisation inhibitor |
| gw9662 | [no description available] | low | 0 | 0 | benzamides | |
| N-[2-(1-cyclohexenyl)ethyl]-4-(4-morpholinylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-methoxy-N-[6-(1-oxobutylamino)-3-pyridinyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-chloro-2-[(2,4-dimethoxyanilino)-oxomethyl]phenyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| [3-[3-(5-methyl-2-furanyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]-phenylmethanone | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| 4-methyl-N-[2-[4-(2-methyl-1-oxopropyl)-1-piperazinyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2-(2-ethyl-5-tetrazolyl)phenyl]-3-(1-tetrazolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2-(2-ethyl-5-tetrazolyl)phenyl]-4-(1-tetrazolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2,5-diethoxy-4-[[oxo-(3,4,5-trimethoxyphenyl)methyl]amino]phenyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| (2,4-difluorophenyl)-[3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]methanone | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| 2-ethoxy-N-[4-(4-morpholinylsulfonyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methyl-N-(2-methyl-5-tetrazolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2,5-dimethoxy-4-[[2-(4-morpholinyl)-1-oxoethyl]amino]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-fluorophenyl)-4-(2-oxolanylmethylsulfamoyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| azidopine | [no description available] | low | 0 | 0 | benzamides | |
| 4-methoxy-N1,N3-bis(3-pyridinyl)benzene-1,3-dicarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| 2,3,4,5,6-pentafluoro-N-(phenylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(1,1-dioxo-3-thiolanyl)-N-(thiophen-2-ylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-methoxyphenyl)-2-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[(4-acetyloxy-3-methoxyphenyl)-oxomethyl]amino]-5-hydroxybenzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-acetamidophenyl)-4-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-acetamidophenyl)-3-chlorobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methoxy-N-(5-methyl-3-isoxazolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-tert-butyl-N-[4-(4-morpholinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(2-fluorophenyl)-4-phenylmethoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methyl-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methyl-N-[4-(4-morpholinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methoxy-N-(3-pyridinylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-methoxy-N-(2-pyridinyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-(4-oxo-3,1-benzoxazin-2-yl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[(4-pyrimidinylthio)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-acetamidophenyl)-2-bromobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(5-acetyl-4-methyl-2-thiazolyl)-4-tert-butylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(5-acetyl-4-methyl-2-thiazolyl)-2-methylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-ethoxy-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3,4-dimethoxyphenyl)-4-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2-[(4-methylanilino)-oxomethyl]phenyl]-3-pyridinecarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-(2,5-dimethyl-1-pyrrolyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-chloro-3-(trifluoromethyl)phenyl]-3-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-(2-methyl-4-thiazolyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-acetamidophenyl)-2-chlorobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-ethoxy-N-(2-thiazolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-bromo-N-(3-methoxyphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(2,4-difluorophenyl)-3-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-[[(4-acetyloxy-3-methoxyphenyl)-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| acetic acid [4-[(4-hydroxyanilino)-oxomethyl]-2-methoxyphenyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-benzamido-2-chlorophenyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-(hydroxymethyl)-N-(phenylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[(3-methylphenyl)-oxomethyl]amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylic acid | [no description available] | low | 0 | 0 | benzamides | |
| 2-chloro-4-methyl-N-[4-(4-methyl-1-piperazinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-ethoxy-N-(2-hydroxyphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[(3-chloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 2-methoxy-N-(4-methylphenyl)-4-(methylthio)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[(4-methoxyphenyl)-oxomethyl]amino]-2-thiophenecarboxylic acid methyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 2-methoxy-3-methyl-N-[4-(4-morpholinylmethyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-anilinophenyl)-3,4-dimethoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-4-methylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[[(6-methyl-4-pyrimidinyl)thio]methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-acetamidophenyl)-2-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-bromo-N-[3-(1-oxopropylamino)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-acetylphenyl)-3-ethoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[(3-bromophenyl)-oxomethyl]amino]-5-hydroxybenzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 1-azepanyl-[4-[(phenylthio)methyl]phenyl]methanone | [no description available] | low | 0 | 0 | benzamides | |
| 4-chloro-N-[4-(2-imidazo[1,2-a]pyridinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3,4,5-triethoxy-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[[3-(4-methoxyphenyl)phenyl]-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 3-[(4-ethoxyphenoxy)methyl]-N,N-diethylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[anilino(oxo)methyl]amino]-N-(phenylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-tert-butyl-N-(4-methyl-3-nitrophenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-methoxyphenyl)-4-[(2-methyl-1-oxopropyl)amino]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-3,4,5-trimethoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-chloro-3-[[(2-methyl-3-nitrophenyl)-oxomethyl]amino]benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-nitrobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-methoxyphenyl)-2-(methylthio)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-[[(3,5-dimethoxyphenyl)-oxomethyl]amino]phenyl]carbamic acid ethyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 2,4-dimethyl-N-[4-(1-pyrrolidinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(7-bromo-3,4-dihydro-2H-1,5-benzodioxepin-8-yl)-3-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 5-chloro-N-(2-furanylmethyl)-2-[[(4-methoxyphenyl)-oxomethyl]amino]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-[(2-bromophenoxy)methyl]-N-[4-[(3,5-dimethyl-1-pyrazolyl)methyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-bromo-5-ethoxy-N-(4-fluorophenyl)-4-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-chloro-N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]-5-(1,2,4-triazol-4-yl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[(3,5-dichloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 4-[4-[[(3,4-dimethylphenyl)-oxomethyl]amino]phenoxy]phthalic acid | [no description available] | low | 0 | 0 | benzamides | |
| 5-ethyl-2-[[oxo-(3,4,5-trimethoxyphenyl)methyl]amino]-3-thiophenecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 2-bromo-N-[3-(1-oxobutylamino)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-chloro-N-[3-nitro-5-(2-pyridinylthio)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-chloro-2-[(2-ethoxyanilino)-oxomethyl]phenyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-[[[3-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 3,4-dimethoxy-N-[4-[oxo(1-piperidinyl)methyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-fluoro-N-[4-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-benzamido-3-methylphenyl)-1,3-benzodioxole-5-carboxamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-benzamidophenyl)-1,3-benzodioxole-5-carboxamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2,2-dichloro-1-(4-chlorophenyl)sulfonylethenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[[3-[2-(4-methylphenyl)sulfonylethylthio]phenyl]-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 4-chloro-N-[3-chloro-4-(4-morpholinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-methoxyphenyl)-4-(1-oxopropylamino)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[5-(4-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]-4-methylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| [2-methoxy-4-(methylthio)phenyl]-[4-(phenylmethyl)-1-piperidinyl]methanone | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| N-[2,5-diethoxy-4-[[(3-methoxyanilino)-sulfanylidenemethyl]amino]phenyl]-4-methylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-[[anilino(sulfanylidene)methyl]amino]-2,5-diethoxyphenyl]-4-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-[[anilino(sulfanylidene)methyl]amino]-2,5-diethoxyphenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-(4-chloro-3-methylphenoxy)acetic acid [4-[(4-methylanilino)-oxomethyl]phenyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| 2-(3-chlorophenoxy)acetic acid [4-[(4-methylanilino)-oxomethyl]phenyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| 2-(4-chloro-2-methylphenoxy)acetic acid [4-[(4-methylanilino)-oxomethyl]phenyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| 3-(1,3-dioxo-2-isoindolyl)propanoic acid [4-[(4-methylanilino)-oxomethyl]phenyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| 5-bromo-2-furancarboxylic acid (3-benzamidophenyl) ester | [no description available] | low | 0 | 0 | benzamides | |
| (4-ethoxyphenyl)-[4-[(4-ethoxyphenyl)-oxomethyl]-1,4-diazepan-1-yl]methanone | [no description available] | low | 0 | 0 | benzamides | |
| [4-[(2-bromophenoxy)methyl]phenyl]-(1-piperidinyl)methanone | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| 3-[(4-bromophenoxy)methyl]-N-(5-methyl-3-isoxazolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-methyl-N-[4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-[methyl(phenyl)sulfamoyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-[(N-methylanilino)-oxomethyl]phenyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[[3-(1-azepanylsulfonyl)-4-chlorophenyl]-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 2-[2-nitro-4-(trifluoromethyl)phenoxy]-N-phenylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-chloro-N-[2-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[[(4-methoxyphenyl)-oxomethyl]amino]methyl]-5-phenyl-3-furancarboxylic acid | [no description available] | low | 0 | 0 | benzamides | |
| N-(3,5-dichlorophenyl)-2-(methanesulfonamido)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(5-chloro-2-methylphenyl)-4-[(4-chloro-1-pyrazolyl)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[2-[(4-chlorophenyl)thio]-1-oxoethyl]amino]-N-(4-methoxyphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methoxy-N-[2-(4-morpholinyl)phenyl]-3-nitrobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-bromo-N-[4-(4-methyl-1-piperazinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-[[[(5-bromo-2-furanyl)-oxomethyl]hydrazo]-oxomethyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 5-bromo-2-methoxy-3-methyl-N-[4-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methoxy-N-[4-[[(1-oxopropylamino)-sulfanylidenemethyl]amino]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[(3,5-dimethoxyphenyl)-oxomethyl]amino]-4,5-dimethoxybenzoic acid methyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 2,4,5-trimethoxy-N-(2-phenylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-ethoxy-N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[[3-methyl-4-[[2-(3-nitrophenoxy)-1-oxoethyl]amino]phenyl]-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 4-methyl-N-[2-methyl-1,3-bis[(4-methyl-1,2,5-oxadiazol-3-yl)oxy]propan-2-yl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| [4-[(2,4-dichlorophenoxy)methyl]phenyl]-(4-methyl-1-piperazinyl)methanone | [no description available] | low | 0 | 0 | benzamides | |
| N-(2-furanylmethyl)-2-[[[2-[(4-methylphenyl)sulfonyl-(phenylmethyl)amino]phenyl]-oxomethyl]amino]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[(2-cyanophenyl)thio]-N-[4-[dimethylamino(oxo)methyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(2-furanylmethyl)-2-[[oxo-(3,4,5-trimethoxyphenyl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-[[(4-nitrophenyl)-oxomethyl]amino]phenyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[(3-benzamidoanilino)-sulfanylidenemethyl]-2-thiophenecarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-chloro-N-[4-[(1-oxo-2-phenylethyl)amino]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3,4-dimethoxyphenyl)-4-[(4-phenyl-1-piperazinyl)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-cyano-N-methyl-N-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-tert-butyl-N-[2,5-dimethoxy-4-[[1-oxo-2-(1-piperidinyl)ethyl]amino]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| (2,6-difluorophenyl)-[4-(5-fluoro-2-methyl-1-benzimidazolyl)-1-piperidinyl]methanone | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| 4-chloro-N-[3-cyano-4-(phenylthio)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| (4-chlorophenyl)-[4-[[(2,4-dichlorophenyl)thio]methyl]-4-hydroxy-1-piperidinyl]methanone | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| N-(4-bromo-2,6-dimethylphenyl)-2-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-[[(3,6-dichloro-2-methoxyphenyl)-oxomethyl]amino]benzoic acid propyl ester | [no description available] | low | 0 | 0 | benzamides | |
| N-(2,4-dichlorophenyl)-4-phenylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-butoxy-N-[4-[4-(2-methyl-1-oxopropyl)-1-piperazinyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| fm19g11 | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-[(4,6-dimethyl-2-pyrimidinyl)sulfamoyl]phenyl]-2-nitrobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[(2,5-dichlorophenoxy)methyl]-N-(2,6-dimethylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[[(3-methyl-1-oxobutyl)amino]-sulfanylidenemethyl]amino]-N-phenylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| acetic acid [4-[[3-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]anilino]-oxomethyl]phenyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| 4-[[(4-tert-butylphenyl)-oxomethyl]amino]-3-methyl-2-sulfanylidene-5-thiazolecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 3-methoxy-N-(2,3,4-trifluorophenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-phenylacetic acid [2-[4-[(4-ethoxyanilino)-oxomethyl]anilino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| 4-[[(2-nitrophenyl)-oxomethyl]amino]benzoic acid propyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[oxo-(2,3,4,5,6-pentafluorophenyl)methyl]amino]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 2-bromo-N-[3-(1-oxopentylamino)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-[(2,4-dichlorophenoxy)methyl]-N-[2-(dimethylamino)ethyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-methoxy-N-[2-(3-methoxyphenoxy)ethyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-(diethylsulfamoyl)phenyl]-4-(4-morpholinylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3,5-dimethyl-N-[4-[(1-oxo-2-phenylethyl)amino]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[[3-[(3-nitrophenyl)sulfamoyl]phenyl]-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 2-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-N-(3-methoxyphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-chloro-3-[(2,5-dimethylphenyl)sulfamoyl]-N-(2-phenylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methyl-N-(2-phenylphenyl)-3-(phenylsulfamoyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[2-[[3-(1,3-benzoxazol-2-yl)anilino]-oxomethyl]phenyl]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 3,4-dimethoxy-N-[4-(2,2,3,3-tetrafluoropropoxy)-3-(trifluoromethyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 1-azepanyl-[2-[4-(difluoromethylthio)anilino]phenyl]methanone | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[(4-tert-butylphenyl)-oxomethyl]amino]-1H-1,2,4-triazole-5-carboxylic acid methyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 2-bromo-N-(4-ethylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-amino-N-(2-methoxyphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-(difluoromethoxy)-N-[5-[[4-(difluoromethylthio)phenyl]methyl]-2-thiazolyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[(4-ethoxyphenyl)sulfonylamino]-N-[2-(4-morpholinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-(dimethylamino)-N-[2-(1,2,4-triazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[(2,5-dimethylphenyl)sulfonylamino]-N-[4-(2-pyrimidinylsulfamoyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[(5-chloro-2-thiophenyl)sulfonylamino]-N-(2-methoxy-5-methylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methoxy-N-[1-methyl-2-oxo-6-(trifluoromethyl)-3-pyridinyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-bromo-3-(trifluoromethyl)phenyl]-2,4,6-trimethylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methyl-N-[1-methyl-2-oxo-6-(trifluoromethyl)-3-pyridinyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-[2-(4-fluoroanilino)-2-oxoethoxy]-3-methoxy-N-[4-(4-methoxyphenyl)-5-methyl-2-thiazolyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[3-[2-(2-carbamoylphenoxy)-1-oxoethyl]-2,5-dimethyl-1-pyrrolyl]propanoic acid methyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 4-methyl-N-[4-(2-methyl-4-thiazolyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 5-(dimethylsulfamoyl)-N-(diphenylmethyl)-2-(1-pyrrolidinyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[(3-fluoro-4-methoxyphenyl)methoxy]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-chloro-2-methoxy-5-methylphenyl)-4-[(3,4-difluorophenyl)sulfonylamino]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[(3-methylphenyl)-oxomethyl]amino]benzoic acid (3,5-dimethyl-4-isoxazolyl)methyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 4-(dimethylsulfamoyl)-N-(3-methylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[5-chloro-2-(4-methyl-1-piperazinyl)phenyl]-3-(dimethylsulfamoyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-methoxy-N-(4-methyl-2-thiazolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-(diethylsulfamoyl)-N-(3,5-dimethylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3,4-dimethyl-N-[4-(4-methylpiperazino)benzyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-(5-oxazolyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N1-(2,6-dimorpholino-3-pyridyl)-4-methylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-3,4-dimethylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| sirtinol | [no description available] | low | 0 | 0 | aldimine; benzamides; naphthols | anti-inflammatory agent; EC 3.5.1.98 (histone deacetylase) inhibitor; Sir2 inhibitor |
| N-[1-(3-methoxyphenyl)-3-(1-naphthalenylamino)-3-oxopropyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-(1-naphthalenylamino)-3-oxo-1-phenylpropyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-chloro-3-(diethylsulfamoyl)-N-(2-nitrophenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3,4,5-trimethoxy-N-[4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-methoxy-2-nitrophenyl)-3-[(2-methyl-1-oxopropyl)amino]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3,4,5-triethoxy-N-[4-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[[4-[[2-(4-chloro-2-methylphenoxy)-1-oxopropyl]amino]phenyl]-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| N-(5-chloro-2-hydroxyphenyl)-2-ethoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2-[(2-furanylmethylamino)-oxomethyl]phenyl]-4-methyl-3-(1-piperidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methoxy-N-[4-[1-[(4-methoxyanilino)-oxomethyl]cyclopentyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-chloro-2-(1-piperidinyl)phenyl]-4-(4-morpholinyl)-3-nitrobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-(6-imidazo[2,1-b]thiazolyl)phenyl]-4-methoxy-3-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| norcisapride | [no description available] | low | 0 | 0 | benzamides | |
| prucalopride | [no description available] | low | 0 | 0 | benzamides | |
| Dihydroalatamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methoxy-N-[2,2,2-trichloro-1-(4-methylanilino)ethyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(2-hydroxy-5-nitrophenyl)-3-nitrobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-(1,3-benzothiazol-2-ylthio)-5-nitrophenyl]-2-fluorobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2-[5-[(4-tert-butylphenyl)methylthio]-1,3,4-oxadiazol-2-yl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-butan-2-yl-4-[4-oxo-3-(phenylmethyl)-2-thiazolidinyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-[3-(2-furanylmethyl)-4-oxo-2-thiazolidinyl]-N-(3-propan-2-yloxypropyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-methyl-N-[1-(4-prop-2-enyl-5-sulfanylidene-1H-1,2,4-triazol-3-yl)ethyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-(4-methoxyphenyl)-2-thiazolyl]-N-(2-oxolanylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-chloro-4-ethoxy-N-[3-(2-oxazolo[5,4-b]pyridinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-[[(3-methoxyphenyl)-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[oxo-[3-(1-piperidinylsulfonyl)phenyl]methyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-ethoxyphenyl)-2-(hydroxymethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(5-acetyl-2-phenyl-4-sulfanylidene-1H-pyrimidin-6-yl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| sb-224289 | [no description available] | low | 0 | 0 | 1,2,4-oxadiazole; azaspiro compound; benzamides; organic heterotetracyclic compound | serotonergic antagonist |
| N-[(4-methylphenyl)methyl]-4-(1-pyrrolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 1-[(4-chlorophenyl)-oxomethyl]-N-[4-(1-piperidinylsulfonyl)phenyl]-3-piperidinecarboxamide | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| N-(4-bromophenyl)-2-[(5,6-dimethyl-4-thieno[2,3-d]pyrimidinyl)thio]benzamide | [no description available] | low | 0 | 0 | benzamides; thienopyrimidine | |
| 4-(3,5-dimethyl-1-pyrazolyl)-N-[2-methoxy-5-(4-morpholinylsulfonyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[5-ethyl-3-[(4-fluorophenyl)-(4-morpholinyl)methyl]-2-thiophenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-cycloheptyl-4-(2-oxolanylmethoxy)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-(4-methoxyphenyl)acetic acid [2-[4-[(4-ethoxyanilino)-oxomethyl]anilino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| 2-methyl-3-nitro-N-[4-[[(1-oxopropylamino)-sulfanylidenemethyl]amino]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2-(3-methyl-1-oxobutyl)-3-oxo-1,2,4-thiadiazol-5-yl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[4-[[(3-chlorophenyl)-oxomethyl]amino]phenyl]propanedioic acid dimethyl ester | [no description available] | low | 0 | 0 | benzamides | |
| N-(3,5-dimethylphenyl)-2-(2-nitroethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-[[(4-tert-butylphenyl)-oxomethyl]amino]phenyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-[(4-ethoxyphenyl)-[4-(2-hydroxyethyl)-1-piperazinyl]methyl]-4,5-dimethyl-2-thiophenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-methoxy-N-(5-phenyl-1,2,4-thiadiazol-3-yl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-chlorophenyl)-4-fluoro-3-(thiophen-2-ylmethylsulfamoyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-acetamido-N-[(4-ethoxy-3-methoxyphenyl)methyl]-4-[(4-methylphenyl)thio]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-(4-morpholinylsulfonyl)phenyl]-4-(2-oxo-1-pyrrolidinyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N,N-dimethylsulfamic acid [3-[(4-methoxyanilino)-oxomethyl]phenyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| N-[1-(benzenesulfonyl)-2,2-dichloroethenyl]-4-methylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-chloro-3-[(4-chlorophenyl)sulfamoyl]phenyl]-4-propan-2-yloxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide | [no description available] | low | 0 | 0 | benzamides; benzodioxoles; imidazoles; pyridines | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
| N-[3-[(2-bromo-5-methylphenyl)sulfamoyl]-4-methoxyphenyl]-4-fluorobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2,5-diethoxy-4-(4-morpholinyl)phenyl]-4-[(3,5-dimethyl-4-isoxazolyl)methoxy]-3-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methyl-N-[2-[(5-oxo-2,3-dihydrothiazolo[2,3-b]quinazolin-3-yl)methylthio]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-cyano-N-[4-thiophen-2-yl-5-(2,2,2-trifluoro-1-oxoethyl)-2-thiazolyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-(1-azepanylsulfonyl)-N-[5-[(4-chlorophenyl)sulfamoyl]-2-hydroxyphenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-(4-fluorophenyl)-2-thiazolyl]-3-methoxy-4-[2-(4-morpholinyl)-2-oxoethoxy]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-chloro-3-(4-morpholinylsulfonyl)phenyl]-4-(2-oxolanylmethoxy)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-[(4-chlorophenyl)methylthio]-1H-1,2,4-triazol-5-yl]-4-cyanobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-(4-methylphenoxy)-N-[2-[oxo(1-piperidinyl)methyl]phenyl]acetamide | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| imd 0354 | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-chlorophenyl)-3-[ethyl(phenyl)sulfamoyl]-4-fluorobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-tert-butyl-N-[3-[4-[3-[[(4-tert-butylphenyl)-oxomethyl]amino]propyl]-1-piperazinyl]propyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-nitro-4-[(6-nitro-4-quinolinyl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-amino-5-chloro-N-[(3R,4S)-1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| tiapridex | [no description available] | low | 0 | 0 | benzamides | |
| [2-methoxy-5-[[4-(4-methylphenyl)-1-phthalazinyl]amino]phenyl]-(1-piperidinyl)methanone | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| axitinib | [no description available] | low | 0 | 0 | aryl sulfide; benzamides; indazoles; pyridines | antineoplastic agent; tyrosine kinase inhibitor; vascular endothelial growth factor receptor antagonist |
| 4-[(2,4-dioxo-1H-thieno[3,2-d]pyrimidin-3-yl)methyl]-N-(3-ethylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| LSM-32377 | [no description available] | low | 0 | 0 | benzamides | |
| ispinesib | [no description available] | low | 0 | 0 | benzamides | |
| fk 866 | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| 4-acetamido-N-(2-amino-5-thiophen-2-ylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| [4-[[4-(1-benzothiophen-2-yl)-2-pyrimidinyl]amino]phenyl]-[4-(1-pyrrolidinyl)-1-piperidinyl]methanone | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| midostaurin | [no description available] | low | 0 | 0 | benzamides; gamma-lactam; indolocarbazole; organic heterooctacyclic compound | antineoplastic agent; EC 2.7.11.13 (protein kinase C) inhibitor |
| bms201038 | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; benzamides; fluorenes; piperidines | anticholesteremic drug; MTP inhibitor |
| cgp 74588 | [no description available] | low | 0 | 0 | benzamides | |
| zm 447439 | [no description available] | low | 0 | 0 | aromatic ether; benzamides; morpholines; polyether; quinazolines; secondary amino compound; tertiary amino compound | antineoplastic agent; apoptosis inducer; Aurora kinase inhibitor |
| tak-715 | [no description available] | low | 0 | 0 | benzamides | |
| masitinib | [no description available] | low | 0 | 0 | 1,3-thiazoles; benzamides; N-alkylpiperazine; pyridines | antineoplastic agent; antirheumatic drug; tyrosine kinase inhibitor |
| N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide | [no description available] | low | 0 | 0 | 1,3,4-oxadiazoles; benzamides; biphenyls; nitrile | EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor |
| betrixaban | [no description available] | low | 0 | 0 | benzamides; guanidines; monochloropyridine; monomethoxybenzene; secondary carboxamide | anticoagulant; EC 3.4.21.6 (coagulation factor Xa) inhibitor |
| nigerloxin | [no description available] | low | 0 | 0 | aromatic ether; benzamides; benzoic acids; phenols; styrenes | antioxidant; Aspergillus metabolite; EC 1.1.1.21 (aldehyde reductase) inhibitor; lipoxygenase inhibitor; radical scavenger |
| myxochelin b | [no description available] | low | 0 | 0 | benzamides; catechols | bacterial metabolite; siderophore |
| fluopicolide | [no description available] | low | 0 | 0 | benzamide fungicide; benzamides; dichlorobenzene; monochloropyridine; organofluorine compound | antifungal agrochemical |
| eluxadoline | [no description available] | low | 0 | 0 | amino acid amide; benzamides; imidazoles; L-phenylalanine derivative; methoxybenzoic acid | delta-opioid receptor antagonist; gastrointestinal drug; kappa-opioid receptor agonist; mu-opioid receptor agonist |
| N-[4-(2-tert-butylphenyl)sulfonylphenyl]-2,3,4-trihydroxy-5-[(2-propan-2-ylphenyl)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[5-[[5-[(4-acetyl-1-piperazinyl)-oxomethyl]-4-methoxy-2-methylphenyl]thio]-2-thiazolyl]-4-[(3,3-dimethylbutan-2-ylamino)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| chir 090 | [no description available] | low | 0 | 0 | acetylenic compound; benzamides; hydroxamic acid; L-threonine derivative; morpholines | antimicrobial agent; EC 3.5.1.108 (UDP-3-O-acyl-N-acetylglucosamine deacetylase) inhibitor; lipopolysaccharide biosynthesis inhibitor |
| ki11502 | [no description available] | low | 0 | 0 | aromatic ether; benzamides; quinolines; thioureas | antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
| az-628 | [no description available] | low | 0 | 0 | benzamides | |
| at 13387 | [no description available] | low | 0 | 0 | benzamides; isoindoles; N-alkylpiperazine; resorcinols; tertiary carboxamide | antineoplastic agent; Hsp90 inhibitor |
| 4-[[[2-(cyclohexylamino)-3,4-dioxo-1-cyclobutenyl]amino]methyl]-N-(4-ethoxyphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| chidamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3,5-dichlorophenyl)-4-[(2,4-dioxo-1H-thieno[3,2-d]pyrimidin-3-yl)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| mdv 3100 | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; benzamides; imidazolidinone; monofluorobenzenes; nitrile; thiocarbonyl compound | androgen antagonist; antineoplastic agent |
| 3-nitro-4-(2-oxolanylmethylamino)-N-(2-phenylethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-({2-[(3-hydroxyphenyl)amino]pyrimidin-4-yl}amino)benzamide | [no description available] | low | 0 | 0 | aminopyrimidine; benzamides | protein kinase inhibitor |
| azd 7545 | [no description available] | low | 0 | 0 | benzamides; monochlorobenzenes; organofluorine compound; secondary carboxamide; sulfone; tertiary alcohol; tertiary carboxamide | EC 2.7.11.2 - [pyruvate dehydrogenase (acetyl-transferring)] kinase inhibitor; hypoglycemic agent |
| N-[3-[2-(4-chloroanilino)-4-thiazolyl]phenyl]-3-(trifluoromethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-(trifluoromethyl)-N-[4-[2-[3-(trifluoromethyl)anilino]-4-thiazolyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-amino-N-[3-methoxy-5-[oxo-[3-(trifluoromethyl)anilino]methyl]phenyl]-5-oxazolecarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-amino-N-[3-methoxy-5-[oxo-[3-(trifluoromethyl)anilino]methyl]phenyl]-4-thiazolecarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-amino-N-[3-methoxy-5-[oxo-[3-(trifluoromethyl)anilino]methyl]phenyl]-4-pyridinecarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-(4-bromophenyl)-N-[5-[[4-[(4-ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)anilino]-oxomethyl]-2-methylphenyl]-1H-pyrazole-5-carboxamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-amino-1-[4-[2-(4-methoxyphenyl)ethylamino]-3-nitrophenyl]-3-oxopropyl]-4-bromobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| nvp-bhg712 | [no description available] | low | 0 | 0 | benzamides | |
| respirantin | [no description available] | low | 0 | 0 | benzamides; cyclodepsipeptide; formamides; phenols | antimicrobial agent; antineoplastic agent; metabolite |
| N-[5-[[5-[(4-acetyl-1-piperazinyl)-oxomethyl]-4-methoxy-2-methylphenyl]thio]-2-thiazolyl]-4-[(3-methylbutan-2-ylamino)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| ph 797804 | [no description available] | low | 0 | 0 | aromatic ether; benzamides; organobromine compound; organofluorine compound; pyridone | anti-inflammatory agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor |
| 2-[(6-chloro-3-pyridinyl)sulfonylamino]-N-[(4-methylphenyl)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[4-(2-hydroxyethylamino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| lde225 | [no description available] | low | 0 | 0 | aminopyridine; aromatic ether; benzamides; biphenyls; morpholines; organofluorine compound; tertiary amino compound | antineoplastic agent; Hedgehog signaling pathway inhibitor; SMO receptor antagonist |
| gdc 0449 | [no description available] | low | 0 | 0 | benzamides; monochlorobenzenes; pyridines; sulfone | antineoplastic agent; Hedgehog signaling pathway inhibitor; SMO receptor antagonist; teratogenic agent |
| 3-[[1-[1-(methylthio)propan-2-yl]-4-piperidinyl]oxy]-N-(2-pyridinylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[1-(dimethylsulfamoyl)-4-piperidinyl]oxy]-N-[(3-methyl-5-isoxazolyl)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| ponatinib | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; acetylenic compound; benzamides; imidazopyridazine; N-methylpiperazine | antineoplastic agent; tyrosine kinase inhibitor |
| N-cyclopropyl-3-{4-[(cyclopropylmethyl)carbamoyl]phenyl}-4-methylbenzamide | [no description available] | low | 0 | 0 | benzamides; biphenyls; cyclopropanes; dicarboxylic acid diamide | EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor |
| 4-tert-butyl-N-[5-[[2-oxo-2-(2-oxolanylmethylamino)ethyl]thio]-1,3,4-thiadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-ethoxy-N-[5-[[2-oxo-2-(2-oxolanylmethylamino)ethyl]thio]-1,3,4-thiadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| GRL-0617 | [no description available] | low | 0 | 0 | benzamides; naphthalenes; secondary carboxamide; substituted aniline | anticoronaviral agent; protease inhibitor |
| n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide | [no description available] | low | 0 | 0 | aminopyrimidine; benzamides; morpholines; nitrile; secondary amino compound; tertiary amino compound | anti-anaemic agent; antineoplastic agent; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor |
| N-(2,6-difluorophenyl)-5-[3-[2-[5-ethyl-2-methoxy-4-[4-(4-methylsulfonyl-1-piperazinyl)-1-piperidinyl]anilino]-4-pyrimidinyl]-2-imidazo[1,2-a]pyridinyl]-2-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| entrectinib | [no description available] | low | 0 | 0 | benzamides; difluorobenzene; indazoles; N-methylpiperazine; oxanes; secondary amino compound; secondary carboxamide | antibacterial agent; antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
| ixazomib | [no description available] | low | 0 | 0 | benzamides; boronic acids; dichlorobenzene; glycine derivative | antineoplastic agent; apoptosis inducer; drug metabolite; orphan drug; proteasome inhibitor |
| N-(2-chlorophenyl)-4-[[2-[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]anilino]-5-fluoro-4-pyrimidinyl]amino]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-(2-thiazolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(2-aminophenyl)-4-[[[(2S,3S)-10-[[cyclohexyl(oxo)methyl]amino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| KOM70144 | [no description available] | low | 0 | 0 | acetamides; benzamides; naphthalenes; secondary carboxamide | anticoronaviral agent; protease inhibitor |
| iwr-1 endo | [no description available] | low | 0 | 0 | benzamides; bridged compound; dicarboximide; quinolines | axin stabilizer; Wnt signalling inhibitor |
| ulixacaltamide | [no description available] | low | 0 | 0 | benzamides; monochlorobenzenes; monofluorobenzenes; piperidines; secondary carboxamide | non-narcotic analgesic; T-type calcium channel blocker |
| xl765 | [no description available] | low | 0 | 0 | aromatic amine; aromatic ether; benzamides; quinoxaline derivative; sulfonamide | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor |
| azd4547 | [no description available] | low | 0 | 0 | benzamides; N-arylpiperazine; pyrazoles | fibroblast growth factor receptor antagonist |
| N-[4-(1-benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2-propenamide | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| entecavir | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| acp-196 | [no description available] | low | 0 | 0 | aromatic amine; benzamides; imidazopyrazine; pyridines; pyrrolidinecarboxamide; secondary carboxamide; tertiary carboxamide; ynone | antineoplastic agent; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor |
| pf-06463922 | [no description available] | low | 0 | 0 | aminopyridine; aromatic ether; azamacrocycle; benzamides; cyclic ether; monofluorobenzenes; nitrile; organic heterotetracyclic compound; pyrazoles | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
| DDR1-IN-1 | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; aromatic ether; benzamides; N-alkylpiperazine; oxindoles; secondary carboxamide | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
| N-[2-methyl-5-[oxo-[3-(1-oxoprop-2-enylamino)-5-(trifluoromethyl)anilino]methyl]phenyl]-5-isoxazolecarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| PF-06446846 | [no description available] | low | 0 | 0 | benzamides; monochloropyridine; piperidines; tertiary carboxamide; triazolopyridine | antilipemic drug; EC 3.4.21.61 (kexin) inhibitor |
| 5,10-methylenetetrahydrofolic acid | [no description available] | low | 0 | 0 | benzamides; methylenetetrahydrofolic acid | |
| N-cyclohexyl-3-methyl-N-[(4-oxo-1H-quinazolin-2-yl)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2,4-dichlorophenoxyacetic acid | [no description available] | low | 0 | 0 | chlorophenoxyacetic acid; dichlorobenzene | agrochemical; defoliant; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; environmental contaminant; phenoxy herbicide; synthetic auxin |
| am 251 | [no description available] | low | 0 | 0 | amidopiperidine; carbohydrazide; dichlorobenzene; organoiodine compound; pyrazoles | antidepressant; antineoplastic agent; apoptosis inducer; CB1 receptor antagonist |
| apraclonidine | [no description available] | low | 0 | 0 | dichlorobenzene; guanidines; imidazolines | alpha-adrenergic agonist; antiglaucoma drug; beta-adrenergic agonist; diagnostic agent; ophthalmology drug |
| bithionol | [no description available] | low | 0 | 0 | aryl sulfide; bridged diphenyl antifungal drug; bridged diphenyl fungicide; dichlorobenzene; organochlorine pesticide; polyphenol | antifungal agrochemical; antiplatyhelmintic drug |
| clenbuterol | [no description available] | low | 0 | 0 | amino alcohol; dichlorobenzene; ethanolamines; primary arylamine; secondary amino compound; substituted aniline | beta-adrenergic agonist; bronchodilator agent; sympathomimetic agent |
| dicamba | [no description available] | low | 0 | 0 | dichlorobenzene; methoxybenzoic acid | agrochemical; environmental contaminant; herbicide; synthetic auxin; xenobiotic |
| dichlobanil | [no description available] | low | 0 | 0 | dichlorobenzene; nitrile | agrochemical; cellulose synthesis inhibitor; environmental contaminant; herbicide; xenobiotic |
| diclofenac | [no description available] | low | 0 | 0 | amino acid; aromatic amine; dichlorobenzene; monocarboxylic acid; secondary amino compound | antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
| dichlorphenamide | [no description available] | low | 0 | 0 | dichlorobenzene; sulfonamide | antiglaucoma drug; EC 4.2.1.1 (carbonic anhydrase) inhibitor; ophthalmology drug |
| diuron | [no description available] | low | 0 | 0 | 3-(3,4-substituted-phenyl)-1,1-dimethylurea; dichlorobenzene | environmental contaminant; mitochondrial respiratory-chain inhibitor; photosystem-II inhibitor; urea herbicide; xenobiotic |
| ethacrynic acid | [no description available] | low | 0 | 0 | aromatic ether; aromatic ketone; dichlorobenzene; monocarboxylic acid | EC 2.5.1.18 (glutathione transferase) inhibitor; ion transport inhibitor; loop diuretic |
| fipronil | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; dichlorobenzene; nitrile; primary amino compound; pyrazoles; sulfoxide | |
| liquid crystal polymer | [no description available] | low | 0 | 0 | conazole fungicide; dichlorobenzene; organobromine compound; oxolanes; triazole fungicide; triazoles | antifungal agrochemical; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor |
| irsogladine | [no description available] | low | 0 | 0 | dichlorobenzene | |
| isoconazole | [no description available] | low | 0 | 0 | dichlorobenzene; ether; imidazoles | |
| lamotrigine | [no description available] | low | 0 | 0 | 1,2,4-triazines; dichlorobenzene; primary arylamine | anticonvulsant; antidepressant; antimanic drug; calcium channel blocker; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; excitatory amino acid antagonist; geroprotector; non-narcotic analgesic; xenobiotic |
| clorgyline | [no description available] | low | 0 | 0 | aromatic ether; dichlorobenzene; terminal acetylenic compound; tertiary amino compound | antidepressant; EC 1.4.3.4 (monoamine oxidase) inhibitor |
| 4-dichlorobenzene | [no description available] | low | 0 | 0 | dichlorobenzene | insecticide |
| methazole | [no description available] | low | 0 | 0 | dichlorobenzene | |
| propanil | [no description available] | low | 0 | 0 | anilide; dichlorobenzene | herbicide |
| triclosan | [no description available] | low | 0 | 0 | aromatic ether; dichlorobenzene; monochlorobenzenes; phenols | antibacterial agent; antimalarial; drug allergen; EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; fungicide; persistent organic pollutant; xenobiotic |
| 2,6-dichlorobenzoic acid | [no description available] | low | 0 | 0 | chlorobenzoic acid; dichlorobenzene | bacterial xenobiotic metabolite |
| 2,5-dichlorobenzoic acid | [no description available] | low | 0 | 0 | chlorobenzoic acid; dichlorobenzene | |
| 2,4-dichlorobenzoic acid | [no description available] | low | 0 | 0 | chlorobenzoic acid; dichlorobenzene | bacterial metabolite |
| 2-dichlorobenzene | [no description available] | low | 0 | 0 | dichlorobenzene | hepatotoxic agent; metabolite |
| 2,4-dichlorotoluene | [no description available] | low | 0 | 0 | dichlorobenzene | |
| dicloran | [no description available] | low | 0 | 0 | aromatic fungicide; dichlorobenzene; nitroaniline | antifungal agrochemical |
| triclocarban | [no description available] | low | 0 | 0 | dichlorobenzene; monochlorobenzenes; phenylureas | antimicrobial agent; antiseptic drug; disinfectant; environmental contaminant; xenobiotic |
| dichlorprop | [no description available] | low | 0 | 0 | aromatic ether; dichlorobenzene; monocarboxylic acid | |
| linuron | [no description available] | low | 0 | 0 | dichlorobenzene; phenylureas | agrochemical; environmental contaminant; herbicide; xenobiotic |
| chlorfenvinphos | [no description available] | low | 0 | 0 | dichlorobenzene; organic phosphate; organochlorine acaricide; organochlorine insecticide; organophosphate insecticide | agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor |
| 1,3-dichlorobenzene | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 2,6-dichloroindophenol | [no description available] | low | 0 | 0 | dichlorobenzene; quinone imine | |
| 3,3',4',5-tetrachlorosalicylanilide | [no description available] | low | 0 | 0 | dichlorobenzene; salicylanilides | drug allergen |
| dichlorobenzyl alcohol | [no description available] | low | 0 | 0 | benzyl alcohols; dichlorobenzene | antiseptic drug |
| 3,4-dichlorophenylurea | [no description available] | low | 0 | 0 | dichlorobenzene; phenylureas | marine xenobiotic metabolite |
| 2,4,2',4'-tetrachlorobiphenyl | [no description available] | low | 0 | 0 | dichlorobenzene; tetrachlorobiphenyl | |
| chloroneb | [no description available] | low | 0 | 0 | aromatic fungicide; dichlorobenzene; dimethoxybenzene | antifungal agrochemical |
| dicloxacillin | [no description available] | low | 0 | 0 | dichlorobenzene; penicillin | antibacterial drug |
| clonidine hydrochloride | [no description available] | low | 0 | 0 | dichlorobenzene | |
| lofexidine | [no description available] | low | 0 | 0 | aromatic ether; carboxamidine; dichlorobenzene; imidazoles | alpha-adrenergic agonist; antihypertensive agent |
| leptophos | [no description available] | low | 0 | 0 | bromobenzenes; dichlorobenzene; organic phosphonate; phosphonic ester | |
| pcb 118 | [no description available] | low | 0 | 0 | dichlorobenzene; pentachlorobiphenyl; trichlorobenzene | |
| 3,4,3',4'-tetrachlorobiphenyl | [no description available] | low | 0 | 0 | dichlorobenzene; tetrachlorobiphenyl | |
| 2,3,3',4,4'-pentachlorobiphenyl | [no description available] | low | 0 | 0 | dichlorobenzene; pentachlorobiphenyl; trichlorobenzene | |
| kc 400 | [no description available] | low | 0 | 0 | dichlorobenzene; tetrachlorobiphenyl | |
| prothiophos | [no description available] | low | 0 | 0 | dichlorobenzene; organic thiophosphate; organosulfur compound | agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; insecticide |
| 2,5-dichlorobiphenyl | [no description available] | low | 0 | 0 | dichlorobenzene; dichlorobiphenyl | |
| 3,5-dichlorobiphenyl | [no description available] | low | 0 | 0 | dichlorobenzene; dichlorobiphenyl | |
| enilconazole | [no description available] | low | 0 | 0 | dichlorobenzene; ether; imidazoles | |
| 2,5,2',5'-tetrachlorobiphenyl | [no description available] | low | 0 | 0 | dichlorobenzene; tetrachlorobiphenyl | |
| 2,3,3',4,4',5-hexachlorobiphenyl | [no description available] | low | 0 | 0 | dichlorobenzene; hexachlorobiphenyl; tetrachlorobenzene | |
| ticrynafen | [no description available] | low | 0 | 0 | aromatic ether; aromatic ketone; dichlorobenzene; monocarboxylic acid; thiophenes | antihypertensive agent; hepatotoxic agent; loop diuretic |
| 2-(4-(2,4-dichlorophenoxy)phenoxy)propionic acid | [no description available] | low | 0 | 0 | aromatic ether; dichlorobenzene; diether; monocarboxylic acid | |
| lonidamine | [no description available] | low | 0 | 0 | dichlorobenzene; indazoles; monocarboxylic acid | antineoplastic agent; antispermatogenic agent; EC 2.7.1.1 (hexokinase) inhibitor; geroprotector |
| vinclozolin | [no description available] | low | 0 | 0 | dicarboximide; dichlorobenzene; olefinic compound; oxazolidinone | |
| dichlorfop-methyl | [no description available] | low | 0 | 0 | aromatic ether; dichlorobenzene; diether; methyl ester | |
| muzolimine | [no description available] | low | 0 | 0 | dichlorobenzene | |
| azaconazole | [no description available] | low | 0 | 0 | conazole fungicide; cyclic ketal; dichlorobenzene; dioxolane; triazole fungicide; triazoles | antifungal agrochemical; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor |
| propiconazole | [no description available] | low | 0 | 0 | conazole fungicide; cyclic ketal; dichlorobenzene; triazole fungicide; triazoles | antifungal agrochemical; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor; environmental contaminant; xenobiotic |
| butoconazole | [no description available] | low | 0 | 0 | aryl sulfide; conazole antifungal drug; dichlorobenzene; imidazole antifungal drug; imidazoles; monochlorobenzenes | |
| dichlozolinate | [no description available] | low | 0 | 0 | dicarboximide; dichlorobenzene; ethyl ester; oxazolidinone | |
| fenticonazole | [no description available] | low | 0 | 0 | aryl sulfide; dichlorobenzene; ether; imidazoles | |
| itraconazole | [no description available] | low | 0 | 0 | aromatic ether; conazole antifungal drug; cyclic ketal; dichlorobenzene; dioxolane; N-arylpiperazine; triazole antifungal drug; triazoles | EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor; Hedgehog signaling pathway inhibitor; P450 inhibitor |
| aripiprazole | [no description available] | low | 0 | 0 | aromatic ether; delta-lactam; dichlorobenzene; N-alkylpiperazine; N-arylpiperazine; quinolone | drug metabolite; H1-receptor antagonist; second generation antipsychotic; serotonergic agonist |
| tobanum | [no description available] | low | 0 | 0 | dichlorobenzene | |
| hexaconazole | [no description available] | low | 0 | 0 | dichlorobenzene; tertiary alcohol; triazoles | chelator |
| sertraline | [no description available] | low | 0 | 0 | dichlorobenzene; secondary amino compound; tetralins | antidepressant; serotonin uptake inhibitor |
| aceclofenac | [no description available] | low | 0 | 0 | amino acid; carboxylic ester; dichlorobenzene; monocarboxylic acid; secondary amino compound | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
| fluphenacur | [no description available] | low | 0 | 0 | aromatic ether; benzoylurea insecticide; dichlorobenzene; N-acylurea; organofluorine compound | |
| guanoclor | [no description available] | low | 0 | 0 | dichlorobenzene | |
| tridiphane | [no description available] | low | 0 | 0 | dichlorobenzene | |
| tetraconazole | [no description available] | low | 0 | 0 | dichlorobenzene; ether; organofluorine compound; triazoles | |
| n-(2,4-dichloro-5-(4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1h-1,2,4-triazol-1-yl)phenyl)methanesulfonamide | [no description available] | low | 0 | 0 | dichlorobenzene; organofluorine compound; sulfonamide; triazoles | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
| fluquinconazole | [no description available] | low | 0 | 0 | conazole fungicide; dichlorobenzene; organofluorine compound; quinazolines; triazole fungicide; triazoles | antifungal agrochemical; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor |
| tolclofos-methyl | [no description available] | low | 0 | 0 | dichlorobenzene; organic thiophosphate | antifungal agrochemical |
| penconazole | [no description available] | low | 0 | 0 | dichlorobenzene; triazoles | |
| chlorfluazuron | [no description available] | low | 0 | 0 | benzoylurea insecticide; dichlorobenzene; organochlorine insecticide; organofluorine insecticide | |
| fenpiclonil | [no description available] | low | 0 | 0 | dichlorobenzene; nitrile; pyrroles | antifungal agrochemical |
| teflubenzuron | [no description available] | low | 0 | 0 | dichlorobenzene; difluorobenzene; N-acylurea | environmental contaminant; insecticide; xenobiotic |
| hexafluoron | [no description available] | low | 0 | 0 | aromatic ether; benzoylurea insecticide; dichlorobenzene; N-acylurea; organochlorine insecticide; organofluorine insecticide | |
| 3,3',5,5'-tetrachlorobiphenyl-4,4'-diol | [no description available] | low | 0 | 0 | dichlorobenzene; hydroxybiphenyls | |
| 4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl | [no description available] | low | 0 | 0 | biphenyls; dichlorobenzene; sulfone | |
| 4'-hydroxydiclofenac | [no description available] | low | 0 | 0 | dichlorobenzene; monocarboxylic acid; phenols; secondary amino compound | allergen; drug metabolite |
| 1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone | [no description available] | low | 0 | 0 | dichlorobenzene; differentiation-inducing factor; monomethoxybenzene; resorcinols | eukaryotic metabolite; signalling molecule |
| 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl-)-1-pentanone | [no description available] | low | 0 | 0 | dichlorobenzene; differentiation-inducing factor; monomethoxybenzene; resorcinols | eukaryotic metabolite; signalling molecule |
| cgp 52432 | [no description available] | low | 0 | 0 | dichlorobenzene | |
| spirodiclofen | [no description available] | low | 0 | 0 | dichlorobenzene; gamma-lactone; organochlorine acaricide; oxaspiro compound | |
| n-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide | [no description available] | low | 0 | 0 | anilide fungicide; aromatic amide; dichlorobenzene; monocarboxylic acid amide; phenols | antifungal agrochemical; EC 1.14.13.72 (methylsterol monooxygenase) inhibitor; sterol biosynthesis inhibitor |
| 2-(2,4-dichlorophenoxy)-N-(3-pyridinyl)acetamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 3,5-dichlorotyrosine | [no description available] | low | 0 | 0 | chloroamino acid; dichlorobenzene; dihalogenated L-tyrosine; non-proteinogenic L-alpha-amino acid | |
| pd 173955 | [no description available] | low | 0 | 0 | aryl sulfide; dichlorobenzene; methyl sulfide; pyridopyrimidine | tyrosine kinase inhibitor |
| mln 4760 | [no description available] | low | 0 | 0 | dichlorobenzene; L-histidine derivative; L-leucine derivative | anti-inflammatory agent; EC 3.4.17.23 (angiotensin-converting enzyme 2) inhibitor |
| olanexidine | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 2-(2,4-dichlorophenoxy)-N-(2-furanylmethyl)acetamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 2-[[5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]thio]acetic acid butyl ester | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 2-[[5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]thio]acetic acid ethyl ester | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 5,6-dichloro-1-ethyl-1,3-dihydro-2h-benzimidazol-2-one | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 3-[(2,6-dichlorophenyl)methylthio]-4-methyl-5-thiophen-2-yl-1,2,4-triazole | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 1-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)ethanol | [no description available] | low | 0 | 0 | dichlorobenzene | |
| N-[2-[5-[(2,4-dichlorophenyl)methylsulfonyl]-1,3,4-oxadiazol-2-yl]ethyl]carbamic acid tert-butyl ester | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 6-(2,4-dichlorophenyl)-1,5-diazabicyclo[3.1.0]hexane | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 3-[(2,4-dichlorophenyl)methylthio]-1,2,4-thiadiazol-5-amine | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 2-(2,4-dichlorophenyl)-3,5-dihydro-1H-pyrazolo[3,4-d]triazol-6-amine | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 5-[(2,4-dichlorophenoxy)methyl]-N-[1-[(2-fluorophenyl)methyl]-3-pyrazolyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 1-[[2-(2,4-dichlorophenoxy)-1-oxoethyl]amino]-3-(4-fluorophenyl)thiourea | [no description available] | low | 0 | 0 | dichlorobenzene | |
| [4-[[5-(2,4-dichlorophenyl)-3-isoxazolyl]-oxomethyl]-1-piperazinyl]-(2-furanyl)methanone | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 5-(2,4-dichlorophenyl)-N-(4-methyl-2-thiazolyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 5-(2,5-dichlorophenyl)-N-(2-propyl-5-tetrazolyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 4-[2-[(3,4-dichlorophenyl)methylthio]-6-[(methylthio)methyl]-4-pyrimidinyl]morpholine | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 3-[5-[(3,4-dichlorophenyl)methylthio]-4-ethyl-1,2,4-triazol-3-yl]-1-phenyl-4-pyridazinone | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 5-[3-[(2,4-dichlorophenyl)methoxy]-2-thiophenyl]-1,2-dihydro-1,2,4-triazole-3-thione | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 2-(2,4-dichlorophenyl)-5-[2-(methylthio)phenyl]-1,3,4-oxadiazole | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 4-[2-[(2,4-dichlorophenyl)methylthio]-6-methyl-4-pyrimidinyl]morpholine | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 4-(2,4-dichlorophenoxy)-N-(3-pyridinyl)butanamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 4-(2,4-dichlorophenoxy)butanoic acid [2-oxo-2-[(phenylmethyl)amino]ethyl] ester | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 2-((3-(2,3-dichlorophenoxy)propyl)amino)ethanol | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 2-(2,4-dichloro-6-methylphenoxy)-N-(2-furanylmethyl)acetamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 4-[3-(2,4-dichlorophenyl)-5-isoxazolyl]-2-pyrimidinamine | [no description available] | low | 0 | 0 | dichlorobenzene | |
| yoda 1 | [no description available] | low | 0 | 0 | aromatic compound; dichlorobenzene; organic sulfide; pyrazines; thiadiazoles | glycine transporter 2 inhibitor; piezo1 agonist |
| 3-[[(2,4-dichlorophenyl)methylthio]methyl]-4-propan-2-yl-1H-1,2,4-triazole-5-thione | [no description available] | low | 0 | 0 | dichlorobenzene | |
| N-[amino(1-pyrrolidinyl)methylidene]-3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolecarboxamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
| N-[2-(2,4-dichlorophenyl)ethyl]-2-[[5-[1-(dimethylamino)propyl]-1,3,4-oxadiazol-2-yl]thio]acetamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
| nnd 502 | [no description available] | low | 0 | 0 | dichlorobenzene | |
| fenchlorazole-ethyl | [no description available] | low | 0 | 0 | dichlorobenzene | |
| omoconazole | [no description available] | low | 0 | 0 | dichlorobenzene | |
| vx-745 | [no description available] | low | 0 | 0 | aryl sulfide; dichlorobenzene; difluorobenzene; pyrimidopyridazine | anti-inflammatory drug; apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor |
| 5-hydroxydiclofenac | [no description available] | low | 0 | 0 | dichlorobenzene; monocarboxylic acid; phenols; secondary amino compound | allergen; drug metabolite |
| fipronil sulfone | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; dichlorobenzene; nitrile; pyrazoles; sulfone | marine xenobiotic metabolite |
| 3-(2-chlorophenyl)-N-[5-(2,4-dichlorophenyl)-1,3,4-thiadiazol-2-yl]-5-methyl-4-isoxazolecarboxamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 3-[2-(2,4-dichlorophenoxy)ethoxy]-6-methyl-2-nitropyridine | [no description available] | low | 0 | 0 | dichlorobenzene | |
| 5-[(2,4-dichlorophenoxy)methyl]-N-[3,5-dimethyl-1-[(2,3,4,5,6-pentafluorophenyl)methyl]-4-pyrazolyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
| (3,5-dichloroanilino)thiourea | [no description available] | low | 0 | 0 | dichlorobenzene | |
| N(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamide | [no description available] | low | 0 | 0 | D-leucine derivative; dichlorobenzene; furoic acid; glycine derivative; guanidines; pyrazolylpiperidine | |
| bosutinib | [no description available] | low | 0 | 0 | aminoquinoline; aromatic ether; dichlorobenzene; N-methylpiperazine; nitrile; tertiary amino compound | antineoplastic agent; tyrosine kinase inhibitor |
| guanabenz acetate | [no description available] | low | 0 | 0 | dichlorobenzene | geroprotector |
| guanabenz | [no description available] | low | 0 | 0 | dichlorobenzene | |
| N-(3,4-dichlorophenyl)-6-(1-imidazolyl)-3-pyridazinamine | [no description available] | low | 0 | 0 | dichlorobenzene | |
| diniconazole | [no description available] | low | 0 | 0 | dichlorobenzene; olefinic compound; secondary alcohol; triazoles | |
| chlorproguanil | [no description available] | low | 0 | 0 | dichlorobenzene | |
| noviflumuron | [no description available] | low | 0 | 0 | aromatic ether; benzoylurea insecticide; dichlorobenzene; organofluorine compound | |
| chir 99021 | [no description available] | low | 0 | 0 | aminopyridine; aminopyrimidine; cyanopyridine; diamine; dichlorobenzene; imidazoles; secondary amino compound | EC 2.7.11.26 (tau-protein kinase) inhibitor |
| vilanterol | [no description available] | low | 0 | 0 | benzyl alcohols; dichlorobenzene; ether; phenols; secondary amino compound | beta-adrenergic agonist; bronchodilator agent |
| gw 842166x | [no description available] | low | 0 | 0 | dichlorobenzene | |
| pha 665752 | [no description available] | low | 0 | 0 | dichlorobenzene; enamide; indolones; N-acylpyrrolidine; pyrrolecarboxamide; secondary carboxamide; sulfone; tertiary carboxamide | antineoplastic agent; c-Met tyrosine kinase inhibitor |
| tafamidis | [no description available] | low | 0 | 0 | 1,3-benzoxazoles; dichlorobenzene; monocarboxylic acid | central nervous system drug |
| gamendazole | [no description available] | low | 0 | 0 | alpha,beta-unsaturated monocarboxylic acid; dichlorobenzene; indazoles; olefinic compound; organofluorine compound | antispermatogenic agent; eukaryotic translation elongation factor 1alpha 1 inhibitor; Hsp90 inhibitor; synthetic oral contraceptive |
| at 7519 | [no description available] | low | 0 | 0 | dichlorobenzene; piperidines; pyrazoles; secondary carboxamide | antineoplastic agent; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor |
| s 1812 | [no description available] | low | 0 | 0 | dichlorobenzene; organochlorine insecticide; organofluorine insecticide | |
| 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine | [no description available] | low | 0 | 0 | aminopyridine; aromatic ether; dichlorobenzene; organofluorine compound; pyrazolylpiperidine; racemate | antineoplastic agent; biomarker; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
| 2-[(2,4-dichlorophenyl)methylthio]-1-methylimidazole | [no description available] | low | 0 | 0 | dichlorobenzene | |
| avilamycin a | [no description available] | low | 0 | 0 | benzoate ester; cyclic acetal; dichlorobenzene; oligosaccharide derivative; ortho ester; oxaspiro compound; phenols; tertiary alpha-hydroxy ketone | antimicrobial agent; bacterial metabolite |
| gsk 1016790a | [no description available] | low | 0 | 0 | 1-benzothiophenes; aromatic primary alcohol; dichlorobenzene; N-acylpiperazine; sulfonamide; tertiary carboxamide | TRPV4 agonist |
| poziotinib | [no description available] | low | 0 | 0 | acrylamides; aromatic ether; dichlorobenzene; diether; monofluorobenzenes; N-acylpiperidine; quinazolines; secondary amino compound; substituted aniline | antineoplastic agent; apoptosis inducer; epidermal growth factor receptor antagonist |
| N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-tetrazolyl)acetamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
| aripiprazole lauroxil | [no description available] | low | 0 | 0 | aromatic ether; delta-lactam; dichlorobenzene; dodecanoate ester; N-alkylpiperazine; N-arylpiperazine; quinolone | H1-receptor antagonist; prodrug; second generation antipsychotic; serotonergic agonist |
| 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea | [no description available] | low | 0 | 0 | aminopyrimidine; dichlorobenzene; N-alkylpiperazine; N-arylpiperazine; phenylureas | antineoplastic agent; fibroblast growth factor receptor antagonist |
| chir 98014 | [no description available] | low | 0 | 0 | aminopyrimidine; C-nitro compound; diaminopyridine; dichlorobenzene; imidazoles; secondary amino compound | antineoplastic agent; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; hypoglycemic agent; tau aggregation inhibitor; Wnt signalling activator |
| LimKi 3 | [no description available] | low | 0 | 0 | 1,3-thiazoles; dichlorobenzene; organofluorine compound; pyrazoles; secondary carboxamide | LIM kinase inhibitor |
| 2-(4-chloroanilino)-5-[(2,3-dichlorophenyl)methyl]-4-thiazolone | [no description available] | low | 0 | 0 | dichlorobenzene |
| Article | Year |
|---|---|
| Involvement of cholecystokinin receptors in the adverse effect of glucocorticoids on diet-induced necrotizing pancreatitis. Surgery, Volume: 106, Issue: 2 | 1989 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| Demonstration of a new resonance peak by proton NMR in rat pancreas stimulated with caerulein. Pancreas, Volume: 5, Issue: 5 | 1990 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |